<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>OLIG2 - AI Gene Review</title>
    <style>
        :root {
            --color-accept: #22c55e;
            --color-remove: #ef4444;
            --color-modify: #f97316;
            --color-keep-non-core: #3b82f6;
            --color-undecided: #6b7280;
            --color-new: #8b5cf6;
            --color-mark-over: #eab308;
            --bg-light: #f9fafb;
            --border-color: #e5e7eb;
            --text-muted: #6b7280;
            --text-primary: #111827;
        }

        * {
            margin: 0;
            padding: 0;
            box-sizing: border-box;
        }

        body {
            font-family: -apple-system, BlinkMacSystemFont, "Segoe UI", Roboto, "Helvetica Neue", Arial, sans-serif;
            line-height: 1.6;
            color: var(--text-primary);
            background-color: #ffffff;
            padding: 2rem;
            max-width: 1400px;
            margin: 0 auto;
        }

        .header {
            border-bottom: 2px solid var(--border-color);
            padding-bottom: 1.5rem;
            margin-bottom: 2rem;
        }

        h1 {
            font-size: 2.5rem;
            font-weight: 700;
            margin-bottom: 0.5rem;
            color: #1f2937;
        }

        .gene-info {
            display: flex;
            gap: 2rem;
            flex-wrap: wrap;
            margin-top: 1rem;
        }

        .info-item {
            display: flex;
            gap: 0.5rem;
        }

        .info-label {
            font-weight: 600;
            color: var(--text-muted);
        }

        .aliases {
            display: flex;
            gap: 0.5rem;
            flex-wrap: wrap;
        }

        .badge {
            padding: 0.25rem 0.75rem;
            border-radius: 9999px;
            font-size: 0.875rem;
            font-weight: 500;
            background-color: var(--bg-light);
            border: 1px solid var(--border-color);
        }

        .status-badge {
            padding: 0.375rem 0.875rem;
            border-radius: 0.375rem;
            font-size: 0.875rem;
            font-weight: 600;
            text-transform: uppercase;
            letter-spacing: 0.025em;
        }

        .status-initialized {
            background-color: #fef3c7;
            color: #92400e;
            border: 1px solid #fde68a;
        }

        .status-in-progress {
            background-color: #dbeafe;
            color: #1e40af;
            border: 1px solid #bfdbfe;
        }

        .status-draft {
            background-color: #fce7f3;
            color: #831843;
            border: 1px solid #fbcfe8;
        }

        .status-complete {
            background-color: #d1fae5;
            color: #065f46;
            border: 1px solid #a7f3d0;
        }

        .description-card {
            background-color: var(--bg-light);
            border: 1px solid var(--border-color);
            border-radius: 0.5rem;
            padding: 1.5rem;
            margin-bottom: 2rem;
        }

        .description-card h2 {
            font-size: 1.25rem;
            margin-bottom: 1rem;
            color: #374151;
        }

        .section {
            margin-bottom: 2.5rem;
        }

        .section-title {
            font-size: 1.5rem;
            font-weight: 600;
            margin-bottom: 1.5rem;
            color: #1f2937;
            border-bottom: 1px solid var(--border-color);
            padding-bottom: 0.5rem;
        }

        .annotations-table {
            width: 100%;
            border-collapse: collapse;
            border: 1px solid var(--border-color);
            border-radius: 0.5rem;
            overflow: hidden;
        }

        .annotations-table thead {
            background-color: var(--bg-light);
        }

        .annotations-table th {
            text-align: left;
            padding: 1rem;
            font-weight: 600;
            border-bottom: 2px solid var(--border-color);
            font-size: 0.875rem;
            text-transform: uppercase;
            letter-spacing: 0.05em;
            color: var(--text-muted);
        }

        .annotations-table td {
            padding: 1rem;
            border-bottom: 1px solid var(--border-color);
        }

        .annotations-table tbody tr:hover {
            background-color: #f9fafb;
        }

        .action-badge {
            display: inline-block;
            padding: 0.375rem 0.75rem;
            border-radius: 0.375rem;
            font-size: 0.875rem;
            font-weight: 600;
            text-transform: uppercase;
            letter-spacing: 0.025em;
        }

        .action-accept {
            background-color: var(--color-accept);
            color: white;
        }

        .action-remove {
            background-color: var(--color-remove);
            color: white;
        }

        .action-modify {
            background-color: var(--color-modify);
            color: white;
        }

        .action-keep_as_non_core {
            background-color: var(--color-keep-non-core);
            color: white;
        }

        .action-undecided {
            background-color: var(--color-undecided);
            color: white;
        }

        .action-new {
            background-color: var(--color-new);
            color: white;
        }

        .action-mark_as_over_annotated {
            background-color: var(--color-mark-over);
            color: white;
        }

        .term-info {
            display: flex;
            flex-direction: column;
            gap: 0.25rem;
        }

        .term-id {
            font-family: monospace;
            font-size: 0.875rem;
            color: var(--text-muted);
        }

        .term-label {
            font-weight: 500;
        }

        .evidence-code {
            font-family: monospace;
            background-color: var(--bg-light);
            padding: 0.125rem 0.375rem;
            border-radius: 0.25rem;
            font-size: 0.875rem;
        }

        .not-badge {
            display: inline-block;
            background-color: #fef2f2;
            color: #991b1b;
            border: 1px solid #fecaca;
            padding: 0.125rem 0.375rem;
            border-radius: 0.25rem;
            font-size: 0.75rem;
            font-weight: 600;
            margin-left: 0.25rem;
        }

        .isoform-badge {
            display: inline-block;
            background-color: #eff6ff;
            color: #1e40af;
            border: 1px solid #bfdbfe;
            padding: 0.125rem 0.375rem;
            border-radius: 0.25rem;
            font-size: 0.75rem;
            margin-top: 0.25rem;
        }

        .core-function-card {
            background-color: white;
            border: 1px solid var(--border-color);
            border-radius: 0.5rem;
            padding: 1.5rem;
            margin-bottom: 1rem;
        }

        .core-function-card h3 {
            font-size: 1.125rem;
            margin-bottom: 1rem;
            color: #1f2937;
        }

        .core-function-statement {
            margin-bottom: 1rem;
            padding: 0.75rem;
            background-color: var(--bg-light);
            border-left: 4px solid var(--color-accept);
            border-radius: 0.25rem;
        }

        .function-annotations {
            display: flex;
            flex-wrap: wrap;
            gap: 0.5rem;
            margin-top: 1rem;
        }

        .reference-item {
            border: 1px solid var(--border-color);
            border-radius: 0.5rem;
            padding: 1rem;
            margin-bottom: 1rem;
        }

        .reference-header {
            display: flex;
            justify-content: space-between;
            align-items: start;
            margin-bottom: 0.75rem;
        }

        .reference-id {
            font-family: monospace;
            font-weight: 600;
            color: #2563eb;
        }

        .supported-by {
            margin-top: 0.5rem;
            padding: 0.5rem;
            background-color: #f3f4f6;
            border-left: 3px solid #3b82f6;
            border-radius: 0.25rem;
            font-size: 0.875rem;
        }

        .supported-by-title {
            font-weight: 600;
            color: #4b5563;
            margin-bottom: 0.25rem;
        }

        .support-item {
            margin-bottom: 0.5rem;
        }

        .support-ref {
            font-weight: 500;
            color: #2563eb;
        }

        .support-text {
            color: #6b7280;
            font-style: italic;
            margin-left: 1rem;
        }

        a.term-link {
            color: #2563eb;
            text-decoration: none;
        }

        a.term-link:hover {
            text-decoration: underline;
        }

        .core-function-terms {
            margin-top: 1rem;
        }

        .function-term-group {
            margin-bottom: 1rem;
        }

        .function-term-label {
            font-weight: 600;
            color: #4b5563;
            margin-bottom: 0.25rem;
        }

        .reference-title {
            font-weight: 500;
            margin-bottom: 0.5rem;
        }

        .findings-list {
            margin-top: 1rem;
            padding-left: 1.5rem;
        }

        .finding-item {
            margin-bottom: 0.75rem;
        }

        .finding-statement {
            font-weight: 500;
            margin-bottom: 0.25rem;
        }

        .finding-text {
            color: var(--text-muted);
            font-size: 0.95rem;
            font-style: italic;
        }

        .proposed-term {
            border: 1px solid var(--border-color);
            border-radius: 0.5rem;
            padding: 1rem;
            margin-bottom: 1rem;
            background-color: #fef3c7;
        }

        .question-card {
            border: 1px solid var(--border-color);
            border-radius: 0.5rem;
            padding: 1rem;
            margin-bottom: 1rem;
            background-color: #dbeafe;
        }

        .experiment-card {
            border: 1px solid var(--border-color);
            border-radius: 0.5rem;
            padding: 1rem;
            margin-bottom: 1rem;
            background-color: #f3e8ff;
        }

        .isoforms-grid {
            display: grid;
            grid-template-columns: repeat(auto-fill, minmax(400px, 1fr));
            gap: 1rem;
        }

        .isoform-card {
            border: 1px solid var(--border-color);
            border-radius: 0.5rem;
            padding: 1rem;
            background-color: white;
            transition: box-shadow 0.2s;
        }

        .isoform-card:hover {
            box-shadow: 0 2px 8px rgba(0, 0, 0, 0.1);
        }

        .functional-isoform-type {
            display: inline-block;
            padding: 0.2rem 0.5rem;
            border-radius: 0.25rem;
            font-size: 0.7rem;
            font-weight: 600;
            text-transform: uppercase;
            letter-spacing: 0.03em;
        }

        .type-SPLICE_VARIANT, .type-SPLICE_CLASS {
            background-color: #dbeafe;
            color: #1e40af;
            border: 1px solid #93c5fd;
        }

        .type-CLEAVAGE_PRODUCT {
            background-color: #fef3c7;
            color: #92400e;
            border: 1px solid #fcd34d;
        }

        .type-MODIFICATION_STATE {
            background-color: #f3e8ff;
            color: #6b21a8;
            border: 1px solid #c4b5fd;
        }

        .type-CONFORMATIONAL_STATE {
            background-color: #dcfce7;
            color: #166534;
            border: 1px solid #86efac;
        }

        .functional-isoform-mappings {
            margin-top: 0.5rem;
            padding: 0.5rem;
            background-color: var(--bg-light);
            border-radius: 0.25rem;
            font-size: 0.85rem;
        }

        .functional-isoform-mappings .mapping-type {
            font-weight: 600;
            color: var(--text-muted);
            font-size: 0.75rem;
        }

        .functional-isoform-go {
            margin-top: 0.5rem;
            display: flex;
            flex-wrap: wrap;
            gap: 0.25rem;
        }

        .go-chip {
            display: inline-block;
            padding: 0.15rem 0.4rem;
            background-color: #ecfdf5;
            color: #047857;
            border: 1px solid #a7f3d0;
            border-radius: 0.25rem;
            font-size: 0.75rem;
            font-family: monospace;
        }

        .isoform-header {
            display: flex;
            justify-content: space-between;
            align-items: center;
            margin-bottom: 0.75rem;
            padding-bottom: 0.5rem;
            border-bottom: 1px solid var(--border-color);
        }

        .isoform-name {
            font-weight: 600;
            font-size: 1.1rem;
            color: #1f2937;
        }

        .isoform-id {
            font-family: monospace;
            font-size: 0.875rem;
            color: var(--text-muted);
        }

        .isoform-sequence-note {
            font-size: 0.875rem;
            color: var(--text-muted);
            margin-bottom: 0.5rem;
            padding: 0.5rem;
            background-color: var(--bg-light);
            border-radius: 0.25rem;
        }

        .isoform-description {
            font-size: 0.95rem;
            line-height: 1.5;
        }

        .collapsible {
            cursor: pointer;
            user-select: none;
        }

        .collapsible:after {
            content: ' ‚ñº';
            font-size: 0.75rem;
        }

        .collapsible.collapsed:after {
            content: ' ‚ñ∫';
        }

        .collapse-content {
            transition: max-height 0.3s ease;
            overflow: hidden;
        }

        .collapsed + .collapse-content {
            max-height: 0;
        }

        .no-data {
            color: var(--text-muted);
            font-style: italic;
            padding: 1rem;
            text-align: center;
            background-color: var(--bg-light);
            border-radius: 0.5rem;
        }

        /* Styling for markdown section summaries with voting */
        .markdown-section summary {
            padding: 0.75rem;
            background: var(--bg-light);
            border-radius: 0.5rem;
            margin-bottom: 0.5rem;
        }

        .markdown-section summary:hover {
            background: #e5e7eb;
        }

        .markdown-section summary .vote-buttons {
            margin-left: auto;
        }

        @media print {
            body {
                padding: 1rem;
            }

            .collapsible:after {
                display: none;
            }

            .collapsed + .collapse-content {
                max-height: none !important;
            }
        }

        @media (max-width: 768px) {
            body {
                padding: 1rem;
            }

            h1 {
                font-size: 2rem;
            }

            .annotations-table {
                font-size: 0.875rem;
            }

            .annotations-table th,
            .annotations-table td {
                padding: 0.5rem;
            }
        }
    </style>
</head>
<body>
    <div class="header">
        <h1>OLIG2</h1>
        <div class="gene-info">
            
            <div class="info-item">
                
                <span class="info-label">UniProt ID:</span>
                <span>
                    <a href="https://www.uniprot.org/uniprotkb/Q13516" target="_blank" class="term-link">
                        Q13516
                    </a>
                </span>
                
            </div>
            
            
            <div class="info-item">
                <span class="info-label">Organism:</span>
                <span>Homo sapiens</span>
            </div>
            
            
            <div class="info-item">
                <span class="info-label">Review Status:</span>
                <span class="status-badge status-complete">
                    COMPLETE
                </span>
            </div>
            
            
        </div>
        <div style="margin-top: 1rem; text-align: center;">
            <a id="feedback-form-link"
               href="#"
               target="_blank"
               style="display: inline-block; padding: 10px 20px; background-color: #4CAF50; color: white; text-decoration: none; border-radius: 5px; font-weight: 600;">
                üìù Provide Detailed Feedback
            </a>
            <script>
                // Construct the form URL with proper encoding
                // Extract organism code from the current page path (e.g., /genes/ARATH/APO1/ -> ARATH)
                const pathParts = window.location.pathname.split('/');
                const genesIndex = pathParts.indexOf('genes');
                let organism = '';
                if (genesIndex !== -1 && pathParts[genesIndex + 1]) {
                    organism = pathParts[genesIndex + 1].toUpperCase();
                }
                const geneSymbol = "OLIG2";
                const speciesGene = organism + ' ' + geneSymbol;
                const formBaseUrl = 'https://docs.google.com/forms/d/e/1FAIpQLSdTot9L6GVkkZYgLQT0E8ZdAJv8RiN5ZgOVkgWNcKSbYvxxzQ/viewform';
                const entryId = '1226477767'; // Correct entry ID for Species/Gene field
                const formUrl = formBaseUrl + '?entry.' + entryId + '=' + encodeURIComponent(speciesGene);
                const feedbackLink = document.getElementById('feedback-form-link');
                feedbackLink.href = formUrl;
                // Add tooltip showing the pre-filled value
                feedbackLink.title = 'Opens form with pre-filled: ' + speciesGene;
            </script>
        </div>
    </div>

    
    <div class="description-card">
        <div style="display: flex; justify-content: space-between; align-items: center;">
            <h2>Gene Description</h2>
            <span class="vote-buttons" data-g="Q13516" data-a="DESCRIPTION: OLIG2 (Oligodendrocyte transcription factor 2) is ..." data-r="" data-act="DESCRIPTION">
                <button class="vote-btn" data-v="up" title="Agree with this description">üëç</button>
                <button class="vote-btn" data-v="down" title="Disagree with this description">üëé</button>
            </span>
        </div>
        <p>OLIG2 (Oligodendrocyte transcription factor 2) is a Class B/E basic helix-loop-helix (bHLH) transcription factor that functions as a master regulator of oligodendrocyte and motor neuron lineage specification in the central nervous system. OLIG2 binds E-box DNA motifs (CANNTG) as homo- or heterodimers with other bHLH proteins, regulating transcription of genes essential for neural cell fate determination. The protein is induced by Sonic hedgehog (Shh) signaling and cooperates with transcription factors NKX2-2, OLIG1, SOX10, and ASCL1 to establish the pMN (motor neuron progenitor) domain of the ventral neural tube, promoting oligodendrocyte precursor cell (OPC) specification and oligodendrocyte differentiation while antagonizing V2/V3 interneuron fates. OLIG2 also functions in cell cycle regulation by repressing p21 and antagonizing p53 acetylation. The protein localizes primarily to the nucleus where it associates with chromatin, though cytoplasmic localization can occur when the nuclear localization signal in the bHLH domain is masked. OLIG2 is a diagnostic marker for diffuse gliomas, where it maintains OPC-like/proneural tumor states.</p>
    </div>
    

    

    

    
    <div class="section">
        <h2 class="section-title">Existing Annotations Review</h2>
        <table class="annotations-table">
            <thead>
                <tr>
                    <th>GO Term</th>
                    <th>Evidence</th>
                    <th>Action</th>
                    <th>Reason</th>
                </tr>
            </thead>
            <tbody>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0000981" target="_blank" class="term-link">
                                    GO:0000981
                                </a>
                            </span>
                            <span class="term-label">DNA-binding transcription factor activity, RNA polymerase II-specific</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IBA</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            GO_REF:0000033
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="Q13516" data-a="GO:0000981" data-r="GO_REF:0000033" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> OLIG2 is a well-established bHLH transcription factor that regulates gene expression during neural development. UniProt confirms OLIG2 is &#34;required for oligodendrocyte and motor neuron specification&#34; and functions as a transcriptional regulator. The bHLH domain (residues 108-162) is essential for DNA binding. This is a core function of OLIG2.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> OLIG2 is definitively a DNA-binding transcription factor. The bHLH domain is well-characterized and the protein functions to regulate transcription of genes involved in oligodendrocyte and motor neuron specification. This IBA annotation accurately reflects the core molecular function.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    UniProtKB:Q13516
                                    
                                </span>
                                
                                <div class="support-text">Required for oligodendrocyte and motor neuron specification in the spinal cord</div>
                                
                            </div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    UniProtKB:Q13516
                                    
                                </span>
                                
                                <div class="support-text">Class B basic helix-loop-helix protein 1</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0005634" target="_blank" class="term-link">
                                    GO:0005634
                                </a>
                            </span>
                            <span class="term-label">nucleus</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IBA</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            GO_REF:0000033
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="Q13516" data-a="GO:0005634" data-r="GO_REF:0000033" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> OLIG2 is primarily a nuclear protein as expected for a transcription factor. UniProt indicates nucleus as the primary subcellular location with evidence from PROSITE-ProRule:PRU00981.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> As a transcription factor, OLIG2 must localize to the nucleus to perform its function. UniProt confirms nuclear localization. The bHLH domain contains a nuclear localization signal that may be masked in the native form until interaction with partner proteins.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    UniProtKB:Q13516
                                    
                                </span>
                                
                                <div class="support-text">SUBCELLULAR LOCATION: Nucleus</div>
                                
                            </div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    UniProtKB:Q13516
                                    
                                </span>
                                
                                <div class="support-text">The NLS contained in the bHLH domain could be masked in the native form</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0007423" target="_blank" class="term-link">
                                    GO:0007423
                                </a>
                            </span>
                            <span class="term-label">sensory organ development</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IBA</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            GO_REF:0000033
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-remove">
                            REMOVE
                        </span>
                        <span class="vote-buttons" data-g="Q13516" data-a="GO:0007423" data-r="GO_REF:0000033" data-act="REMOVE">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> OLIG2 is specifically involved in oligodendrocyte and motor neuron specification in the CNS (brain and spinal cord). There is no evidence that OLIG2 functions in sensory organ (eye, ear, nose) development. This IBA annotation appears to be an over-propagation from other bHLH family members that do function in sensory organs.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> OLIG2&#39;s documented functions are restricted to oligodendrocyte differentiation and motor neuron specification in the neural tube and CNS. UniProt describes its function as &#34;Required for oligodendrocyte and motor neuron specification in the spinal cord, as well as for the development of somatic motor neurons in the hindbrain.&#34; There is no mention of sensory organ development. The IBA propagation from other bHLH family members is inappropriate here as OLIG2 has specialized neural tube functions distinct from sensory organ development. This is likely phylogenetic over-propagation from other family members like ATOH1 or NEUROD1 which do function in sensory development.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    UniProtKB:Q13516
                                    
                                </span>
                                
                                <div class="support-text">Required for oligodendrocyte and motor neuron specification in the spinal cord, as well as for the development of somatic motor neurons in the hindbrain</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0070888" target="_blank" class="term-link">
                                    GO:0070888
                                </a>
                            </span>
                            <span class="term-label">E-box binding</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IBA</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            GO_REF:0000033
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="Q13516" data-a="GO:0070888" data-r="GO_REF:0000033" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> bHLH transcription factors characteristically bind E-box sequences (CANNTG). OLIG2 contains a canonical bHLH domain and is expected to bind E-box motifs. The SELEX study (PMID:28473536) systematically analyzed DNA binding of human transcription factors including bHLH proteins.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> E-box binding is the canonical DNA binding specificity for bHLH transcription factors. OLIG2&#39;s bHLH domain (residues 108-162) is well-conserved and the protein belongs to the class B bHLH family. This is a core molecular function.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    UniProtKB:Q13516
                                    
                                </span>
                                
                                <div class="support-text">Class B basic helix-loop-helix protein 1</div>
                                
                            </div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/28473536" target="_blank" class="term-link">
                                        PMID:28473536
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">systematic analysis of DNA binding specificities of full-length TFs</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0045944" target="_blank" class="term-link">
                                    GO:0045944
                                </a>
                            </span>
                            <span class="term-label">positive regulation of transcription by RNA polymerase II</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IBA</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            GO_REF:0000033
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="Q13516" data-a="GO:0045944" data-r="GO_REF:0000033" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> OLIG2 functions as a transcription factor that promotes oligodendrocyte and motor neuron gene expression programs. It cooperates with other factors like ZNF488 to activate transcription of oligodendrocyte differentiation genes.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> OLIG2 is documented to promote oligodendrocyte differentiation by activating target genes. UniProt states it &#34;Functions together with ZNF488 to promote oligodendrocyte differentiation.&#34; This positive transcriptional regulation is a core function.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    UniProtKB:Q13516
                                    
                                </span>
                                
                                <div class="support-text">Functions together with ZNF488 to promote oligodendrocyte differentiation</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0061564" target="_blank" class="term-link">
                                    GO:0061564
                                </a>
                            </span>
                            <span class="term-label">axon development</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IBA</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            GO_REF:0000033
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-keepasnoncore">
                            KEEP AS NON CORE
                        </span>
                        <span class="vote-buttons" data-g="Q13516" data-a="GO:0061564" data-r="GO_REF:0000033" data-act="KEEP_AS_NON_CORE">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> OLIG2&#39;s primary functions are in oligodendrocyte and motor neuron cell fate specification. While oligodendrocytes myelinate axons, OLIG2 itself does not directly regulate axon development processes. Motor neurons do extend axons, but OLIG2&#39;s role is in specifying motor neuron identity, not in axon growth or guidance per se.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Axon development is an indirect downstream consequence of OLIG2&#39;s role in motor neuron specification. OLIG2 specifies motor neuron identity; the resulting motor neurons then extend axons. However, OLIG2 is not known to directly regulate axon development genes or processes. This is a secondary effect rather than a core function. The annotation is not wrong but represents a downstream phenotypic effect.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    UniProtKB:Q13516
                                    
                                </span>
                                
                                <div class="support-text">Required for oligodendrocyte and motor neuron specification in the spinal cord</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0003677" target="_blank" class="term-link">
                                    GO:0003677
                                </a>
                            </span>
                            <span class="term-label">DNA binding</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IEA</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            GO_REF:0000043
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="Q13516" data-a="GO:0003677" data-r="GO_REF:0000043" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> OLIG2 contains a bHLH domain that mediates DNA binding. This is a more general term than the more specific annotations for E-box binding and transcription factor activity.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> This is a valid general annotation. OLIG2&#39;s bHLH domain binds DNA. While more specific terms like E-box binding (GO:0070888) are also present, keeping this general annotation provides appropriate coverage. The IEA from UniProt keyword mapping is appropriate.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    UniProtKB:Q13516
                                    
                                </span>
                                
                                <div class="support-text">Class B basic helix-loop-helix protein 1</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0003700" target="_blank" class="term-link">
                                    GO:0003700
                                </a>
                            </span>
                            <span class="term-label">DNA-binding transcription factor activity</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IEA</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            GO_REF:0000120
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="Q13516" data-a="GO:0003700" data-r="GO_REF:0000120" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> This is the parent term of GO:0000981 (RNA polymerase II-specific). OLIG2 is clearly a DNA-binding transcription factor.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Valid but more general than GO:0000981 which is also annotated. Both annotations are acceptable - the IEA provides a broader term while the IBA provides the more specific Pol II-specific term.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    UniProtKB:Q13516
                                    
                                </span>
                                
                                <div class="support-text">Required for oligodendrocyte and motor neuron specification</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0005634" target="_blank" class="term-link">
                                    GO:0005634
                                </a>
                            </span>
                            <span class="term-label">nucleus</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IEA</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            GO_REF:0000120
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="Q13516" data-a="GO:0005634" data-r="GO_REF:0000120" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> Duplicate of the IBA annotation for nucleus. OLIG2 localizes to the nucleus as expected for a transcription factor.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Correct annotation. Having both IBA and IEA evidence for nuclear localization is fine - they represent independent evidence sources confirming the same localization.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    UniProtKB:Q13516
                                    
                                </span>
                                
                                <div class="support-text">SUBCELLULAR LOCATION: Nucleus</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0005737" target="_blank" class="term-link">
                                    GO:0005737
                                </a>
                            </span>
                            <span class="term-label">cytoplasm</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IEA</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            GO_REF:0000120
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="Q13516" data-a="GO:0005737" data-r="GO_REF:0000120" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> UniProt indicates OLIG2 is also found in the cytoplasm. The nuclear localization signal in the bHLH domain may be masked, allowing cytoplasmic localization until partner protein interaction triggers nuclear import.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> UniProt explicitly states cytoplasmic localization by similarity evidence. The annotation notes that the NLS may be masked in the native form, explaining dual nuclear/cytoplasmic distribution.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    UniProtKB:Q13516
                                    
                                </span>
                                
                                <div class="support-text">Cytoplasm {ECO:0000250}</div>
                                
                            </div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    UniProtKB:Q13516
                                    
                                </span>
                                
                                <div class="support-text">The NLS contained in the bHLH domain could be masked in the native form and translocation to the nucleus could be mediated by interaction either with class E bHLH partner protein or with NKX2-2</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0006355" target="_blank" class="term-link">
                                    GO:0006355
                                </a>
                            </span>
                            <span class="term-label">regulation of DNA-templated transcription</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IEA</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            GO_REF:0000002
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="Q13516" data-a="GO:0006355" data-r="GO_REF:0000002" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> OLIG2 is a transcription factor that regulates gene expression. This general biological process term accurately describes its function.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Correct general term for OLIG2&#39;s role as a transcriptional regulator. While more specific terms for positive regulation are also present, this broader term appropriately captures the general function.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    UniProtKB:Q13516
                                    
                                </span>
                                
                                <div class="support-text">Transcription; Transcription regulation</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0021778" target="_blank" class="term-link">
                                    GO:0021778
                                </a>
                            </span>
                            <span class="term-label">oligodendrocyte cell fate specification</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IEA</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            GO_REF:0000002
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="Q13516" data-a="GO:0021778" data-r="GO_REF:0000002" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> OLIG2 is essential for oligodendrocyte cell fate specification. This is a core function. Note on specification vs commitment distinction: &#34;Specification&#34; is the appropriate term because early OLIG2+ cells in the pMN domain can give rise to EITHER motor neurons OR oligodendrocytes depending on developmental timing and signals - the fate is reversible and context-dependent, which is the definition of specification per Slack (2011).
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> This is a core function of OLIG2. UniProt explicitly states OLIG2 is &#34;Required for oligodendrocyte and motor neuron specification.&#34; The protein establishes the pMN domain which gives rise to both motor neurons (early) and oligodendrocytes (later). The term &#34;specification&#34; (not &#34;commitment&#34;) is appropriate because OLIG2+ cells retain plasticity to become either cell type depending on developmental context.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    UniProtKB:Q13516
                                    
                                </span>
                                
                                <div class="support-text">Required for oligodendrocyte and motor neuron specification in the spinal cord</div>
                                
                            </div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    file:human/OLIG2/OLIG2-deep-research-falcon.md
                                    
                                </span>
                                
                                <div class="support-text">OLIG2 orchestrates neuron-glia fate decisions and is required for OPC specification and oligodendrocyte differentiation</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0021779" target="_blank" class="term-link">
                                    GO:0021779
                                </a>
                            </span>
                            <span class="term-label">oligodendrocyte cell fate commitment</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">TAS</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            file:human/OLIG2/OLIG2-deep-research-falcon.md
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-new">
                            NEW
                        </span>
                        <span class="vote-buttons" data-g="Q13516" data-a="GO:0021779" data-r="file:human/OLIG2/OLIG2-deep-research-falcon.md" data-act="NEW">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> OLIG2 is also involved in oligodendrocyte cell fate commitment, which occurs after specification when OPCs become irreversibly restricted to the oligodendrocyte lineage. OLIG2 remains expressed in OPCs and is required for maintaining oligodendrocyte lineage identity.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> While GO:0021778 (specification) captures OLIG2&#39;s early role in the pMN domain where fate is still plastic, OLIG2 also functions in the later commitment stage. Once cells progress to the OPC stage, OLIG2 (together with factors like SOX10 and NKX2.2) maintains commitment to the oligodendrocyte lineage. This annotation complements the specification term by capturing OLIG2&#39;s continued role throughout oligodendrogenesis.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    UniProtKB:Q13516
                                    
                                </span>
                                
                                <div class="support-text">Required for oligodendrocyte and motor neuron specification in the spinal cord</div>
                                
                            </div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    file:human/OLIG2/OLIG2-deep-research-falcon.md
                                    
                                </span>
                                
                                <div class="support-text">OLIG2 is required for OPC specification and oligodendrocyte differentiation</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0030182" target="_blank" class="term-link">
                                    GO:0030182
                                </a>
                            </span>
                            <span class="term-label">neuron differentiation</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IEA</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            GO_REF:0000002
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-modify">
                            MODIFY
                        </span>
                        <span class="vote-buttons" data-g="Q13516" data-a="GO:0030182" data-r="GO_REF:0000002" data-act="MODIFY">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> OLIG2 promotes motor neuron differentiation in the spinal cord and hindbrain. This general term is appropriate but more specific terms exist.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> While technically correct, OLIG2 specifically promotes motor neuron differentiation, not general neuron differentiation. In fact, OLIG2 antagonizes V2 and V3 interneuron fates. A more specific term would better capture OLIG2&#39;s function.
                        </div>
                        
                        
                        <div style="margin-top: 0.5rem;">
                            <strong>Proposed replacements:</strong>
                            
                            <span class="badge">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0021522" target="_blank" class="term-link">
                                    spinal cord motor neuron differentiation
                                </a>
                            </span>
                            
                        </div>
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    UniProtKB:Q13516
                                    
                                </span>
                                
                                <div class="support-text">Required for oligodendrocyte and motor neuron specification in the spinal cord, as well as for the development of somatic motor neurons in the hindbrain</div>
                                
                            </div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    UniProtKB:Q13516
                                    
                                </span>
                                
                                <div class="support-text">Antagonist of V2 interneuron and of NKX2-2-induced V3 interneuron development</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0042552" target="_blank" class="term-link">
                                    GO:0042552
                                </a>
                            </span>
                            <span class="term-label">myelination</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IEA</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            GO_REF:0000002
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-keepasnoncore">
                            KEEP AS NON CORE
                        </span>
                        <span class="vote-buttons" data-g="Q13516" data-a="GO:0042552" data-r="GO_REF:0000002" data-act="KEEP_AS_NON_CORE">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> OLIG2 promotes oligodendrocyte differentiation, and oligodendrocytes are responsible for myelination in the CNS. However, OLIG2 itself does not directly participate in the myelination process.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Myelination is an indirect downstream effect of OLIG2&#39;s role in oligodendrocyte specification. OLIG2 specifies oligodendrocyte fate; the resulting oligodendrocytes then myelinate axons. OLIG2 is not expressed in mature myelinating oligodendrocytes and does not directly regulate myelin genes. This is a secondary phenotypic consequence rather than a direct function.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    UniProtKB:Q13516
                                    
                                </span>
                                
                                <div class="support-text">Required for oligodendrocyte and motor neuron specification</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0046983" target="_blank" class="term-link">
                                    GO:0046983
                                </a>
                            </span>
                            <span class="term-label">protein dimerization activity</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IEA</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            GO_REF:0000002
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="Q13516" data-a="GO:0046983" data-r="GO_REF:0000002" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> bHLH transcription factors function as dimers. OLIG2&#39;s bHLH domain mediates homo- and heterodimerization with other bHLH proteins.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Protein dimerization is essential for bHLH transcription factor function. OLIG2 interacts with NKX2-2 and ZNF488 through its bHLH domain. This is a core molecular function required for DNA binding and transcriptional activity.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    UniProtKB:Q13516
                                    
                                </span>
                                
                                <div class="support-text">The bHLH is essential for interaction with NKX2-2</div>
                                
                            </div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    UniProtKB:Q13516
                                    
                                </span>
                                
                                <div class="support-text">Interacts with NKX2-2. Interacts with ZNF488</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0048709" target="_blank" class="term-link">
                                    GO:0048709
                                </a>
                            </span>
                            <span class="term-label">oligodendrocyte differentiation</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IEA</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            GO_REF:0000002
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="Q13516" data-a="GO:0048709" data-r="GO_REF:0000002" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> OLIG2 is required for oligodendrocyte differentiation. This is a core biological process function of the protein.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Oligodendrocyte differentiation is one of the primary functions of OLIG2. UniProt states it &#34;Functions together with ZNF488 to promote oligodendrocyte differentiation.&#34; This IEA annotation accurately captures a core function.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    UniProtKB:Q13516
                                    
                                </span>
                                
                                <div class="support-text">Functions together with ZNF488 to promote oligodendrocyte differentiation</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:1990837" target="_blank" class="term-link">
                                    GO:1990837
                                </a>
                            </span>
                            <span class="term-label">sequence-specific double-stranded DNA binding</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IEA</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            GO_REF:0000117
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="Q13516" data-a="GO:1990837" data-r="GO_REF:0000117" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> OLIG2 binds specific DNA sequences (E-boxes) through its bHLH domain. This annotation from ARBA machine learning is appropriate.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> OLIG2&#39;s bHLH domain binds E-box sequences specifically. This is a valid molecular function annotation that is also supported by IDA evidence (PMID:28473536).
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    UniProtKB:Q13516
                                    
                                </span>
                                
                                <div class="support-text">Class B basic helix-loop-helix protein 1</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0005515" target="_blank" class="term-link">
                                    GO:0005515
                                </a>
                            </span>
                            <span class="term-label">protein binding</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IPI</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/32296183" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:32296183
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    A reference map of the human binary protein interactome.
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-remove">
                            REMOVE
                        </span>
                        <span class="vote-buttons" data-g="Q13516" data-a="GO:0005515" data-r="PMID:32296183" data-act="REMOVE">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> The HuRI study (PMID:32296183) identified protein-protein interactions for OLIG2 using yeast two-hybrid screens. However, GO:0005515 &#34;protein binding&#34; is an uninformative term that should be avoided.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> &#34;Protein binding&#34; (GO:0005515) is too general to be informative. The HuRI paper is a large-scale interactome study that does not characterize specific functional interactions of OLIG2. Per curation guidelines, this term should be replaced with more specific binding terms. OLIG2&#39;s known specific interactions (with NKX2-2, ZNF488, class E bHLH proteins) are functionally relevant but this generic annotation does not capture them appropriately.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/32296183" target="_blank" class="term-link">
                                        PMID:32296183
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">we present a human &#39;all-by-all&#39; reference interactome map of human binary protein interactions, or &#39;HuRI&#39;</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0000981" target="_blank" class="term-link">
                                    GO:0000981
                                </a>
                            </span>
                            <span class="term-label">DNA-binding transcription factor activity, RNA polymerase II-specific</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IEA</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            GO_REF:0000107
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="Q13516" data-a="GO:0000981" data-r="GO_REF:0000107" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> Duplicate of the IBA annotation. OLIG2 is an RNA Pol II-specific transcription factor.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> This IEA from Ensembl Compara ortholog transfer is consistent with the IBA annotation. Having multiple evidence types supporting the same annotation increases confidence.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    UniProtKB:Q13516
                                    
                                </span>
                                
                                <div class="support-text">Transcription; Transcription regulation</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0042802" target="_blank" class="term-link">
                                    GO:0042802
                                </a>
                            </span>
                            <span class="term-label">identical protein binding</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IEA</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            GO_REF:0000107
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="Q13516" data-a="GO:0042802" data-r="GO_REF:0000107" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> bHLH proteins can form homodimers as well as heterodimers. OLIG2 likely homodimerizes through its bHLH domain.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Homodimerization is a common property of bHLH transcription factors. While OLIG2&#39;s heterodimeric interactions are better characterized (with NKX2-2, ZNF488, class E bHLH partners), homodimerization is plausible and consistent with the protein family.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    UniProtKB:Q13516
                                    
                                </span>
                                
                                <div class="support-text">Class B basic helix-loop-helix protein 1</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0071837" target="_blank" class="term-link">
                                    GO:0071837
                                </a>
                            </span>
                            <span class="term-label">HMG box domain binding</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IEA</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            GO_REF:0000107
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-undecided">
                            UNDECIDED
                        </span>
                        <span class="vote-buttons" data-g="Q13516" data-a="GO:0071837" data-r="GO_REF:0000107" data-act="UNDECIDED">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> OLIG2 interacts with NKX2-2, which contains a homeodomain. However, NKX2-2 does not contain an HMG box domain. This annotation may be an error in ortholog transfer.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> The annotation source is Ensembl Compara ortholog transfer. NKX2-2, a known OLIG2 partner, has a homeodomain but not an HMG box. SOX proteins have HMG boxes and interact with bHLH factors in neural development, but specific OLIG2-HMG box protein interactions are not well documented. Unable to verify this annotation without additional evidence.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    UniProtKB:Q13516
                                    
                                </span>
                                
                                <div class="support-text">Interacts with NKX2-2. Interacts with ZNF488</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:1990837" target="_blank" class="term-link">
                                    GO:1990837
                                </a>
                            </span>
                            <span class="term-label">sequence-specific double-stranded DNA binding</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IDA</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/28473536" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:28473536
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    Impact of cytosine methylation on DNA binding specificities ...
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="Q13516" data-a="GO:1990837" data-r="PMID:28473536" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> The Taipale lab SELEX study systematically characterized DNA binding specificities of human transcription factors. OLIG2 was among the 542 TFs analyzed.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> This IDA annotation is based on direct experimental evidence from methylation-sensitive SELEX analysis. The study provides systematic characterization of transcription factor DNA binding specificities. This is a core molecular function of OLIG2.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/28473536" target="_blank" class="term-link">
                                        PMID:28473536
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">By analysis of 542 human TFs with methylation-sensitive SELEX (systematic evolution of ligands by exponential enrichment)</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0000785" target="_blank" class="term-link">
                                    GO:0000785
                                </a>
                            </span>
                            <span class="term-label">chromatin</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">ISA</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            GO_REF:0000113
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="Q13516" data-a="GO:0000785" data-r="GO_REF:0000113" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> Transcription factors bind to chromatin to regulate gene expression. OLIG2 is expected to associate with chromatin as part of its function.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> As a DNA-binding transcription factor, OLIG2 functions on chromatin. The ISA annotation from TFClass database is appropriate for a sequence- specific transcription factor.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    UniProtKB:Q13516
                                    
                                </span>
                                
                                <div class="support-text">Chromosomal rearrangement; Cytoplasm; Developmental protein; DNA-binding</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0000981" target="_blank" class="term-link">
                                    GO:0000981
                                </a>
                            </span>
                            <span class="term-label">DNA-binding transcription factor activity, RNA polymerase II-specific</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">ISA</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            GO_REF:0000113
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="Q13516" data-a="GO:0000981" data-r="GO_REF:0000113" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> Third annotation for the same term from TFClass database. OLIG2 is classified as a sequence-specific DNA binding transcription factor.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> This ISA annotation from TFClass provides additional evidence for OLIG2&#39;s function as an RNA Pol II-specific transcription factor. Multiple evidence types converge on this core function.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    UniProtKB:Q13516
                                    
                                </span>
                                
                                <div class="support-text">Transcription; Transcription regulation</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0006338" target="_blank" class="term-link">
                                    GO:0006338
                                </a>
                            </span>
                            <span class="term-label">chromatin remodeling</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">TAS</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            file:human/OLIG2/OLIG2-deep-research-cyberian.md
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-new">
                            NEW
                        </span>
                        <span class="vote-buttons" data-g="Q13516" data-a="GO:0006338" data-r="file:human/OLIG2/OLIG2-deep-research-cyberian.md" data-act="NEW">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> OLIG2 functions as a chromatin pre-patterning factor that recruits the SWI/SNF chromatin remodeler BRG1/SMARCA4 to oligodendrocyte-specific enhancers before differentiation begins. This OLIG2-BRG1 axis is required for initiating oligodendrocyte lineage progression. OLIG2 also recruits SETDB1 for H3K9me3 repressive modification.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> This function is documented in Yu et al. 2013 (Cell) and represents a key mechanistic insight into how OLIG2 regulates oligodendrocyte differentiation at the chromatin level. The chromatin pre-patterning function is distinct from OLIG2&#39;s direct transcriptional regulation and is not currently annotated in GO.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    file:human/OLIG2/OLIG2-deep-research-cyberian.md
                                    
                                </span>
                                
                                <div class="support-text">OLIG2 functions as a &#39;pre-patterning factor&#39; that directs BRG1 to oligodendrocyte-specific enhancers before differentiation begins</div>
                                
                            </div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    file:human/OLIG2/OLIG2-deep-research-cyberian.md
                                    
                                </span>
                                
                                <div class="support-text">Approximately 71% of BRG1 binding regions contain E-box motifs recognized by OLIG2</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
            </tbody>
        </table>
    </div>
    

    
    <div class="section">
        <h2 class="section-title">Core Functions</h2>
        
        <div class="core-function-card">
            
            <div style="display: flex; justify-content: space-between; align-items: center;">
                <h3>OLIG2 acts as a DNA-binding transcription factor that binds E-box motifs to activate transcription of oligodendrocyte lineage genes, driving oligodendrocyte precursor cell (OPC) specification and oligodendrocyte differentiation. This represents the primary core function of OLIG2 as a master regulator of oligodendrogenesis.</h3>
                <span class="vote-buttons" data-g="Q13516" data-a="FUNCTION: OLIG2 acts as a DNA-binding transcription factor t..." data-r="" data-act="CORE_FUNCTION">
                    <button class="vote-btn" data-v="up" title="Agree with this core function">üëç</button>
                    <button class="vote-btn" data-v="down" title="Disagree with this core function">üëé</button>
                </span>
            </div>
            

            <div class="core-function-terms">
                
                <div class="function-term-group">
                    <div class="function-term-label">Molecular Function:</div>
                    <span class="badge">
                        <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0000981" target="_blank" class="term-link">
                            DNA-binding transcription factor activity, RNA polymerase II-specific
                        </a>
                    </span>
                </div>
                

                
                <div class="function-term-group">
                    <div class="function-term-label">Directly Involved In:</div>
                    <div class="function-annotations">
                        
                        <span class="badge">
                            <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0021778" target="_blank" class="term-link">
                                oligodendrocyte cell fate specification
                            </a>
                        </span>
                        
                        <span class="badge">
                            <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0048709" target="_blank" class="term-link">
                                oligodendrocyte differentiation
                            </a>
                        </span>
                        
                        <span class="badge">
                            <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0045944" target="_blank" class="term-link">
                                positive regulation of transcription by RNA polymerase II
                            </a>
                        </span>
                        
                    </div>
                </div>
                

                
                <div class="function-term-group">
                    <div class="function-term-label">Cellular Locations:</div>
                    <div class="function-annotations">
                        
                        <span class="badge">
                            <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0005634" target="_blank" class="term-link">
                                nucleus
                            </a>
                        </span>
                        
                        <span class="badge">
                            <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0000785" target="_blank" class="term-link">
                                chromatin
                            </a>
                        </span>
                        
                    </div>
                </div>
                

                

                
            </div>

            
        </div>
        
        <div class="core-function-card">
            
            <div style="display: flex; justify-content: space-between; align-items: center;">
                <h3>OLIG2 functions as a transcriptional regulator to specify motor neuron fate in the pMN domain of the ventral neural tube. OLIG2 cooperates with NKX2-2 to establish motor neuron identity while antagonizing V2 and V3 interneuron differentiation.</h3>
                <span class="vote-buttons" data-g="Q13516" data-a="FUNCTION: OLIG2 functions as a transcriptional regulator to ..." data-r="" data-act="CORE_FUNCTION">
                    <button class="vote-btn" data-v="up" title="Agree with this core function">üëç</button>
                    <button class="vote-btn" data-v="down" title="Disagree with this core function">üëé</button>
                </span>
            </div>
            

            <div class="core-function-terms">
                
                <div class="function-term-group">
                    <div class="function-term-label">Molecular Function:</div>
                    <span class="badge">
                        <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0000981" target="_blank" class="term-link">
                            DNA-binding transcription factor activity, RNA polymerase II-specific
                        </a>
                    </span>
                </div>
                

                
                <div class="function-term-group">
                    <div class="function-term-label">Directly Involved In:</div>
                    <div class="function-annotations">
                        
                        <span class="badge">
                            <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0021522" target="_blank" class="term-link">
                                spinal cord motor neuron differentiation
                            </a>
                        </span>
                        
                        <span class="badge">
                            <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0045944" target="_blank" class="term-link">
                                positive regulation of transcription by RNA polymerase II
                            </a>
                        </span>
                        
                    </div>
                </div>
                

                
                <div class="function-term-group">
                    <div class="function-term-label">Cellular Locations:</div>
                    <div class="function-annotations">
                        
                        <span class="badge">
                            <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0005634" target="_blank" class="term-link">
                                nucleus
                            </a>
                        </span>
                        
                    </div>
                </div>
                

                

                
            </div>

            
        </div>
        
        <div class="core-function-card">
            
            <div style="display: flex; justify-content: space-between; align-items: center;">
                <h3>OLIG2 binds E-box DNA sequences (CANNTG) through its bHLH domain, providing sequence-specific DNA recognition that underlies its transcriptional regulatory function in neural cell fate determination.</h3>
                <span class="vote-buttons" data-g="Q13516" data-a="FUNCTION: OLIG2 binds E-box DNA sequences (CANNTG) through i..." data-r="" data-act="CORE_FUNCTION">
                    <button class="vote-btn" data-v="up" title="Agree with this core function">üëç</button>
                    <button class="vote-btn" data-v="down" title="Disagree with this core function">üëé</button>
                </span>
            </div>
            

            <div class="core-function-terms">
                
                <div class="function-term-group">
                    <div class="function-term-label">Molecular Function:</div>
                    <span class="badge">
                        <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0070888" target="_blank" class="term-link">
                            E-box binding
                        </a>
                    </span>
                </div>
                

                
                <div class="function-term-group">
                    <div class="function-term-label">Directly Involved In:</div>
                    <div class="function-annotations">
                        
                        <span class="badge">
                            <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0006355" target="_blank" class="term-link">
                                regulation of DNA-templated transcription
                            </a>
                        </span>
                        
                    </div>
                </div>
                

                
                <div class="function-term-group">
                    <div class="function-term-label">Cellular Locations:</div>
                    <div class="function-annotations">
                        
                        <span class="badge">
                            <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0005634" target="_blank" class="term-link">
                                nucleus
                            </a>
                        </span>
                        
                        <span class="badge">
                            <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0000785" target="_blank" class="term-link">
                                chromatin
                            </a>
                        </span>
                        
                    </div>
                </div>
                

                

                
            </div>

            
        </div>
        
        <div class="core-function-card">
            
            <div style="display: flex; justify-content: space-between; align-items: center;">
                <h3>OLIG2 forms homo- and heterodimers through its bHLH domain, which is essential for DNA binding and transcriptional activity. Phosphorylation at Serine 147 regulates dimerization preference: phosphorylated OLIG2 forms homodimers that function as transcriptional repressors and promote motor neuron fate, while dephosphorylated OLIG2 forms heterodimers with NGN2 and E47, sequestering NGN2 from pro-neural functions and promoting oligodendrocyte fate (PMID:21382552). OLIG2 also heterodimerizes with NKX2-2 and ZNF488 to regulate distinct aspects of neural development.</h3>
                <span class="vote-buttons" data-g="Q13516" data-a="FUNCTION: OLIG2 forms homo- and heterodimers through its bHL..." data-r="" data-act="CORE_FUNCTION">
                    <button class="vote-btn" data-v="up" title="Agree with this core function">üëç</button>
                    <button class="vote-btn" data-v="down" title="Disagree with this core function">üëé</button>
                </span>
            </div>
            

            <div class="core-function-terms">
                
                <div class="function-term-group">
                    <div class="function-term-label">Molecular Function:</div>
                    <span class="badge">
                        <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0046983" target="_blank" class="term-link">
                            protein dimerization activity
                        </a>
                    </span>
                </div>
                

                
                <div class="function-term-group">
                    <div class="function-term-label">Directly Involved In:</div>
                    <div class="function-annotations">
                        
                        <span class="badge">
                            <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0006355" target="_blank" class="term-link">
                                regulation of DNA-templated transcription
                            </a>
                        </span>
                        
                    </div>
                </div>
                

                
                <div class="function-term-group">
                    <div class="function-term-label">Cellular Locations:</div>
                    <div class="function-annotations">
                        
                        <span class="badge">
                            <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0005634" target="_blank" class="term-link">
                                nucleus
                            </a>
                        </span>
                        
                    </div>
                </div>
                

                

                
            </div>

            
        </div>
        
        <div class="core-function-card">
            
            <div style="display: flex; justify-content: space-between; align-items: center;">
                <h3>OLIG2 functions as a chromatin pre-patterning factor that recruits the SWI/SNF chromatin remodeler BRG1/SMARCA4 to oligodendrocyte-specific enhancers before differentiation begins. Approximately 71% of BRG1 binding regions contain E-box motifs recognized by OLIG2. This OLIG2-BRG1 axis is required for initiating oligodendrocyte lineage progression. OLIG2 also recruits SETDB1 for H3K9me3 repressive modification on genes like Sox11 that must be silenced during oligodendrocyte maturation.</h3>
                <span class="vote-buttons" data-g="Q13516" data-a="FUNCTION: OLIG2 functions as a chromatin pre-patterning fact..." data-r="" data-act="CORE_FUNCTION">
                    <button class="vote-btn" data-v="up" title="Agree with this core function">üëç</button>
                    <button class="vote-btn" data-v="down" title="Disagree with this core function">üëé</button>
                </span>
            </div>
            

            <div class="core-function-terms">
                
                <div class="function-term-group">
                    <div class="function-term-label">Molecular Function:</div>
                    <span class="badge">
                        <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0000981" target="_blank" class="term-link">
                            DNA-binding transcription factor activity, RNA polymerase II-specific
                        </a>
                    </span>
                </div>
                

                
                <div class="function-term-group">
                    <div class="function-term-label">Directly Involved In:</div>
                    <div class="function-annotations">
                        
                        <span class="badge">
                            <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0048709" target="_blank" class="term-link">
                                oligodendrocyte differentiation
                            </a>
                        </span>
                        
                        <span class="badge">
                            <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0006338" target="_blank" class="term-link">
                                chromatin remodeling
                            </a>
                        </span>
                        
                    </div>
                </div>
                

                
                <div class="function-term-group">
                    <div class="function-term-label">Cellular Locations:</div>
                    <div class="function-annotations">
                        
                        <span class="badge">
                            <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0000785" target="_blank" class="term-link">
                                chromatin
                            </a>
                        </span>
                        
                        <span class="badge">
                            <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0005634" target="_blank" class="term-link">
                                nucleus
                            </a>
                        </span>
                        
                    </div>
                </div>
                

                

                
            </div>

            
            <div style="margin-top: 1rem; padding-top: 1rem; border-top: 1px solid var(--border-color);">
                <strong>Supporting Evidence:</strong>
                <ul class="findings-list">
                    
                    <li class="finding-item">
                        <span class="reference-id">
                            
                            file:human/OLIG2/OLIG2-deep-research-cyberian.md
                            
                        </span>
                        
                        <div class="finding-text">OLIG2 functions as a &#39;pre-patterning factor&#39; that directs BRG1 to oligodendrocyte-specific enhancers before differentiation begins</div>
                        
                    </li>
                    
                    <li class="finding-item">
                        <span class="reference-id">
                            
                            file:human/OLIG2/OLIG2-deep-research-cyberian.md
                            
                        </span>
                        
                        <div class="finding-text">OLIG2 recruits the histone methyltransferase SETDB1 for H3K9me3 modification. This repressive epigenetic mechanism targets genes like Sox11</div>
                        
                    </li>
                    
                </ul>
            </div>
            
        </div>
        
    </div>
    

    
    <div class="section">
        <h2 class="section-title collapsible">References</h2>
        <div class="collapse-content">
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://github.com/geneontology/go-site/blob/master/metadata/gorefs/goref-0000002.md" target="_blank" class="term-link">
                            GO_REF:0000002
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">Gene Ontology annotation through association of InterPro records with GO terms</div>
                
                
                <ul class="findings-list">
                    
                    <li class="finding-item">
                        <div class="finding-statement">Provides IEA annotations based on InterPro domain content</div>
                        
                    </li>
                    
                </ul>
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://github.com/geneontology/go-site/blob/master/metadata/gorefs/goref-0000033.md" target="_blank" class="term-link">
                            GO_REF:0000033
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">Annotation inferences using phylogenetic trees</div>
                
                
                <ul class="findings-list">
                    
                    <li class="finding-item">
                        <div class="finding-statement">Source of IBA annotations propagated from characterized family members</div>
                        
                    </li>
                    
                </ul>
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://github.com/geneontology/go-site/blob/master/metadata/gorefs/goref-0000043.md" target="_blank" class="term-link">
                            GO_REF:0000043
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">Gene Ontology annotation based on UniProtKB/Swiss-Prot keyword mapping</div>
                
                
                <ul class="findings-list">
                    
                    <li class="finding-item">
                        <div class="finding-statement">Maps UniProt keywords to GO terms</div>
                        
                    </li>
                    
                </ul>
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://github.com/geneontology/go-site/blob/master/metadata/gorefs/goref-0000107.md" target="_blank" class="term-link">
                            GO_REF:0000107
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">Automatic transfer of experimentally verified manual GO annotation data to orthologs using Ensembl Compara</div>
                
                
                <ul class="findings-list">
                    
                    <li class="finding-item">
                        <div class="finding-statement">Transfers annotations from orthologs with experimental evidence</div>
                        
                    </li>
                    
                </ul>
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://github.com/geneontology/go-site/blob/master/metadata/gorefs/goref-0000113.md" target="_blank" class="term-link">
                            GO_REF:0000113
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">Gene Ontology annotation of human sequence-specific DNA binding transcription factors (DbTFs) based on the TFClass database</div>
                
                
                <ul class="findings-list">
                    
                    <li class="finding-item">
                        <div class="finding-statement">Provides ISA annotations for transcription factors classified in TFClass</div>
                        
                    </li>
                    
                </ul>
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://github.com/geneontology/go-site/blob/master/metadata/gorefs/goref-0000117.md" target="_blank" class="term-link">
                            GO_REF:0000117
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">Electronic Gene Ontology annotations created by ARBA machine learning models</div>
                
                
                <ul class="findings-list">
                    
                    <li class="finding-item">
                        <div class="finding-statement">Machine learning-based annotation predictions</div>
                        
                    </li>
                    
                </ul>
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://github.com/geneontology/go-site/blob/master/metadata/gorefs/goref-0000120.md" target="_blank" class="term-link">
                            GO_REF:0000120
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">Combined Automated Annotation using Multiple IEA Methods</div>
                
                
                <ul class="findings-list">
                    
                    <li class="finding-item">
                        <div class="finding-statement">Combines multiple IEA sources for consensus annotations</div>
                        
                    </li>
                    
                </ul>
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://pubmed.ncbi.nlm.nih.gov/28473536" target="_blank" class="term-link">
                            PMID:28473536
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">Impact of cytosine methylation on DNA binding specificities of human transcription factors.</div>
                
                
                <ul class="findings-list">
                    
                    <li class="finding-item">
                        <div class="finding-statement">Systematically characterized DNA binding specificities of 542 human TFs using SELEX</div>
                        
                        <div class="finding-text">"By analysis of 542 human TFs with methylation-sensitive SELEX"</div>
                        
                    </li>
                    
                    <li class="finding-item">
                        <div class="finding-statement">OLIG2 was among the transcription factors analyzed</div>
                        
                        <div class="finding-text">"systematic analysis of DNA binding specificities of full-length TFs"</div>
                        
                    </li>
                    
                </ul>
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://pubmed.ncbi.nlm.nih.gov/32296183" target="_blank" class="term-link">
                            PMID:32296183
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">A reference map of the human binary protein interactome.</div>
                
                
                <ul class="findings-list">
                    
                    <li class="finding-item">
                        <div class="finding-statement">Large-scale yeast two-hybrid interactome mapping (HuRI)</div>
                        
                        <div class="finding-text">"we present a human &#39;all-by-all&#39; reference interactome map"</div>
                        
                    </li>
                    
                    <li class="finding-item">
                        <div class="finding-statement">Identified protein-protein interactions for OLIG2</div>
                        
                        <div class="finding-text">"HuRI has approximately four times as many such interactions"</div>
                        
                    </li>
                    
                </ul>
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        file:human/OLIG2/OLIG2-deep-research-falcon.md
                        
                    </span>
                </div>
                
                <div class="reference-title">Deep research synthesis on OLIG2 function</div>
                
                
                <ul class="findings-list">
                    
                    <li class="finding-item">
                        <div class="finding-statement">OLIG2 is a Class B/E basic helix-loop-helix transcription factor that binds E-box DNA motifs to regulate lineage programs</div>
                        
                    </li>
                    
                    <li class="finding-item">
                        <div class="finding-statement">OLIG2 orchestrates neuron-glia fate decisions and is required for OPC specification and oligodendrocyte differentiation</div>
                        
                    </li>
                    
                    <li class="finding-item">
                        <div class="finding-statement">OLIG2 represses p21 and antagonizes p53 acetylation to support replication competence</div>
                        
                    </li>
                    
                    <li class="finding-item">
                        <div class="finding-statement">Functional partners include ASCL1, SOX10, and NKX2.2 in the oligodendroglial gene regulatory network</div>
                        
                    </li>
                    
                    <li class="finding-item">
                        <div class="finding-statement">OLIG2 is induced by Sonic hedgehog (Shh) and participates in cross-talk with FGF and EGFR signaling</div>
                        
                    </li>
                    
                </ul>
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        file:human/OLIG2/OLIG2-deep-research-cyberian.md
                        
                    </span>
                </div>
                
                <div class="reference-title">Comprehensive OLIG2 gene research with detailed citations</div>
                
                
                <ul class="findings-list">
                    
                    <li class="finding-item">
                        <div class="finding-statement">OLIG2 homodimers function as transcriptional repressors while heterodimers with E47 can activate transcription</div>
                        
                        <div class="finding-text">"OLIG2 homodimers tend to function as transcriptional repressors, while heterodimers with E47 can activate transcription of target genes such as the Sox10 enhancer"</div>
                        
                    </li>
                    
                    <li class="finding-item">
                        <div class="finding-statement">Phosphorylation of OLIG2 at Serine 147 regulates the motor neuron-to-oligodendrocyte fate switch</div>
                        
                        <div class="finding-text">"Serine 147, located within the helix-loop-helix domain, is the key regulatory residue. When phosphorylated, OLIG2 preferentially forms homodimers...when S147 is dephosphorylated, OLIG2 shifts to preferentially forming heterodimers with NGN2"</div>
                        
                    </li>
                    
                    <li class="finding-item">
                        <div class="finding-statement">OLIG2 interacts with chromatin remodeler BRG1/SMARCA4 to initiate oligodendrocyte differentiation</div>
                        
                        <div class="finding-text">"OLIG2 functions as a &#39;pre-patterning factor&#39; that directs BRG1 to oligodendrocyte-specific enhancers before differentiation begins"</div>
                        
                    </li>
                    
                    <li class="finding-item">
                        <div class="finding-statement">OLIG2 recruits SETDB1 for H3K9me3 repressive modification on genes like Sox11</div>
                        
                        <div class="finding-text">"OLIG2 recruits the histone methyltransferase SETDB1 for H3K9me3 modification. This repressive epigenetic mechanism targets genes like Sox11"</div>
                        
                    </li>
                    
                    <li class="finding-item">
                        <div class="finding-statement">Nuclear-to-cytoplasmic translocation of OLIG2 is essential for astrocyte differentiation</div>
                        
                        <div class="finding-text">"The translocation of OLIG2 to the cytoplasm is promoted by activated AKT kinase through the PI3K signaling pathway"</div>
                        
                    </li>
                    
                </ul>
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://pubmed.ncbi.nlm.nih.gov/11567617" target="_blank" class="term-link">
                            PMID:11567617
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">The bHLH transcription factor Olig2 promotes oligodendrocyte differentiation in collaboration with Nkx2.2</div>
                
                
                <ul class="findings-list">
                    
                    <li class="finding-item">
                        <div class="finding-statement">OLIG2 and NKX2.2 co-expression promotes oligodendrocyte differentiation through transcriptional repression</div>
                        
                        <div class="finding-text">"Coexpression of Olig2 with Nkx2.2 in the spinal cord promotes ectopic and precocious oligodendrocyte differentiation. Both proteins function as transcriptional repressors in this assay."</div>
                        
                    </li>
                    
                </ul>
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://pubmed.ncbi.nlm.nih.gov/12121626" target="_blank" class="term-link">
                            PMID:12121626
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">The basic helix-loop-helix factor olig2 is essential for the development of motoneuron and oligodendrocyte lineages</div>
                
                
                <ul class="findings-list">
                    
                    <li class="finding-item">
                        <div class="finding-statement">OLIG2 knockout mice lose both motor neurons and oligodendrocytes, with cells converting to astrocyte fate</div>
                        
                        <div class="finding-text">"motoneurons are largely eliminated and oligodendrocytes are not produced"</div>
                        
                    </li>
                    
                    <li class="finding-item">
                        <div class="finding-statement">First evidence that a single gene controls specification of two neural cell types</div>
                        
                        <div class="finding-text">"Our data provide the first evidence that a single gene mutation leads to the loss of two cell types, motoneuron and oligodendrocyte."</div>
                        
                    </li>
                    
                </ul>
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://pubmed.ncbi.nlm.nih.gov/21382552" target="_blank" class="term-link">
                            PMID:21382552
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">Phosphorylation regulates OLIG2 cofactor choice and the motor neuron-oligodendrocyte fate switch</div>
                
                
                <ul class="findings-list">
                    
                    <li class="finding-item">
                        <div class="finding-statement">S147 phosphorylation state determines motor neuron vs oligodendrocyte fate</div>
                        
                        <div class="finding-text">"We found that Serine 147 in the helix-loop-helix domain of OLIG2 was phosphorylated during MN production and dephosphorylated at the onset of OLP genesis"</div>
                        
                    </li>
                    
                    <li class="finding-item">
                        <div class="finding-statement">S147A mutation abolishes motor neuron production without preventing oligodendrocyte production</div>
                        
                        <div class="finding-text">"Mutating Serine 147 to Alanine (S147A) abolished MN production without preventing OLP production in transgenic mice, chicks, or cultured P19 cells"</div>
                        
                    </li>
                    
                </ul>
                
            </div>
            
        </div>
    </div>
    


    
    <div class="section">
        <h2 class="section-title">Suggested Questions for Experts</h2>
        
        <div class="question-card">
            <div style="display: flex; justify-content: space-between; align-items: start;">
                <div style="flex: 1;">
                    <p><strong>Q:</strong> What are the specific gene targets of OLIG2 in oligodendrocyte vs motor neuron specification programs?</p>
                    
                </div>
                <span class="vote-buttons" data-g="Q13516" data-a="Q: What are the specific gene targets of OLIG2 in oli..." data-r="" data-act="QUESTION">
                    <button class="vote-btn" data-v="up" title="Good question to ask">üëç</button>
                    <button class="vote-btn" data-v="down" title="Not a useful question">üëé</button>
                </span>
            </div>
        </div>
        
        <div class="question-card">
            <div style="display: flex; justify-content: space-between; align-items: start;">
                <div style="flex: 1;">
                    <p><strong>Q:</strong> How does OLIG2 switch from promoting motor neuron to oligodendrocyte fate at different developmental stages?</p>
                    
                </div>
                <span class="vote-buttons" data-g="Q13516" data-a="Q: How does OLIG2 switch from promoting motor neuron ..." data-r="" data-act="QUESTION">
                    <button class="vote-btn" data-v="up" title="Good question to ask">üëç</button>
                    <button class="vote-btn" data-v="down" title="Not a useful question">üëé</button>
                </span>
            </div>
        </div>
        
        <div class="question-card">
            <div style="display: flex; justify-content: space-between; align-items: start;">
                <div style="flex: 1;">
                    <p><strong>Q:</strong> What is the role of OLIG2 phosphorylation and other post-translational modifications in regulating its activity?</p>
                    
                </div>
                <span class="vote-buttons" data-g="Q13516" data-a="Q: What is the role of OLIG2 phosphorylation and othe..." data-r="" data-act="QUESTION">
                    <button class="vote-btn" data-v="up" title="Good question to ask">üëç</button>
                    <button class="vote-btn" data-v="down" title="Not a useful question">üëé</button>
                </span>
            </div>
        </div>
        
    </div>
    

    
    <div class="section">
        <h2 class="section-title">Suggested Experiments</h2>
        
        <div class="experiment-card">
            <div style="display: flex; justify-content: space-between; align-items: start;">
                <div style="flex: 1;">
                    
                    <p><strong>Experiment:</strong> ChIP-seq in neural progenitor cells to identify direct OLIG2 target genes and binding motifs in a mammalian cellular context.</p>
                    
                    
                    <p style="margin-top: 0.5rem;"><em>Hypothesis: OLIG2 binds E-box sequences in promoters of oligodendrocyte and motor neuron specification genes</em></p>
                    
                    
                    <p style="margin-top: 0.5rem;">Type: ChIP-seq</p>
                    
                </div>
                <span class="vote-buttons" data-g="Q13516" data-a="EXPERIMENT: ChIP-seq in neural progenitor cells to identify di..." data-r="" data-act="EXPERIMENT">
                    <button class="vote-btn" data-v="up" title="Useful experiment">üëç</button>
                    <button class="vote-btn" data-v="down" title="Not a useful experiment">üëé</button>
                </span>
            </div>
        </div>
        
        <div class="experiment-card">
            <div style="display: flex; justify-content: space-between; align-items: start;">
                <div style="flex: 1;">
                    
                    <p><strong>Experiment:</strong> Time-course RNA-seq of OLIG2 knockout vs wild-type neural progenitors to identify genes regulated during motor neuron and oligodendrocyte differentiation.</p>
                    
                    
                    <p style="margin-top: 0.5rem;"><em>Hypothesis: OLIG2 activates motor neuron and oligodendrocyte specification genes while repressing alternative neural fates</em></p>
                    
                    
                    <p style="margin-top: 0.5rem;">Type: RNA-seq</p>
                    
                </div>
                <span class="vote-buttons" data-g="Q13516" data-a="EXPERIMENT: Time-course RNA-seq of OLIG2 knockout vs wild-type..." data-r="" data-act="EXPERIMENT">
                    <button class="vote-btn" data-v="up" title="Useful experiment">üëç</button>
                    <button class="vote-btn" data-v="down" title="Not a useful experiment">üëé</button>
                </span>
            </div>
        </div>
        
        <div class="experiment-card">
            <div style="display: flex; justify-content: space-between; align-items: start;">
                <div style="flex: 1;">
                    
                    <p><strong>Experiment:</strong> Mass spectrometry-based identification of OLIG2 interaction partners in neural progenitor cells to characterize cell type-specific complexes.</p>
                    
                    
                    <p style="margin-top: 0.5rem;"><em>Hypothesis: OLIG2 forms distinct transcriptional complexes during motor neuron vs oligodendrocyte specification</em></p>
                    
                    
                    <p style="margin-top: 0.5rem;">Type: IP-MS</p>
                    
                </div>
                <span class="vote-buttons" data-g="Q13516" data-a="EXPERIMENT: Mass spectrometry-based identification of OLIG2 in..." data-r="" data-act="EXPERIMENT">
                    <button class="vote-btn" data-v="up" title="Useful experiment">üëç</button>
                    <button class="vote-btn" data-v="down" title="Not a useful experiment">üëé</button>
                </span>
            </div>
        </div>
        
    </div>
    

    

    <!-- Additional Documentation Sections -->
    
    <div class="section">
        <h2 class="section-title">üìö Additional Documentation</h2>
        
        <details class="markdown-section">
            <summary style="display: flex; justify-content: space-between; align-items: center; cursor: pointer;">
                <div style="flex: 1;">
                    <h3 style="display: inline;">Deep Research Cyberian</h3>
                    <span style="font-size: 0.8rem; color: #666; margin-left: 1rem;">(OLIG2-deep-research-cyberian.md)</span>
                </div>
                <div class="vote-buttons" data-g="Q13516" data-a="DOC: Deep Research Cyberian" data-r="" data-act="DOCUMENTATION" style="display: flex; gap: 0.25rem;">
                    <button class="vote-btn" data-v="up" title="This documentation is helpful">üëç</button>
                    <button class="vote-btn" data-v="down" title="This documentation needs improvement">üëé</button>
                </div>
            </summary>
            <div class="markdown-content">
                <hr />
<p>provider: cyberian<br />
model: deep-research<br />
cached: false<br />
start_time: '2026-01-11T18:21:38.645248'<br />
end_time: '2026-01-11T18:41:26.312642'<br />
duration_seconds: 1187.67<br />
template_file: templates/gene_research_go_focused.md<br />
template_variables:<br />
  organism: human<br />
  gene_id: OLIG2<br />
  gene_symbol: OLIG2<br />
  uniprot_accession: Q13516<br />
  protein_description: 'RecName: Full=Oligodendrocyte transcription factor 2; Short=Oligo2;<br />
    AltName: Full=Class B basic helix-loop-helix protein 1; Short=bHLHb1; AltName:<br />
    Full=Class E basic helix-loop-helix protein 19; Short=bHLHe19; AltName: Full=Protein<br />
    kinase C-binding protein 2; AltName: Full=Protein kinase C-binding protein RACK17;'<br />
  gene_info: Name=OLIG2; Synonyms=BHLHB1, BHLHE19, PRKCBP2, RACK17;<br />
  organism_full: Homo sapiens (Human).<br />
  protein_family: Not specified in UniProt<br />
  protein_domains: bHLH_dom. (IPR011598); bHLH_transcription_factors. (IPR050359);<br />
    HLH_DNA-bd_sf. (IPR036638); Olig2_bHLH. (IPR032658); HLH (PF00010)<br />
provider_config:<br />
  timeout: 1800<br />
  max_retries: 3<br />
  parameters:<br />
    allowed_domains: []<br />
    agent_type: claude<br />
    port: 3284<br />
    skip_permissions: true<br />
citation_count: 16</p>
<hr />
<h2 id="question">Question</h2>
<h1 id="gene-research-for-functional-annotation">Gene Research for Functional Annotation</h1>
<h2 id="critical-geneprotein-identification-context">‚ö†Ô∏è CRITICAL: Gene/Protein Identification Context</h2>
<p><strong>BEFORE YOU BEGIN RESEARCH:</strong> You MUST verify you are researching the CORRECT gene/protein. Gene symbols can be ambiguous, especially for less well-characterized genes from non-model organisms.</p>
<h3 id="target-geneprotein-identity-from-uniprot">Target Gene/Protein Identity (from UniProt):</h3>
<ul>
<li><strong>UniProt Accession:</strong> Q13516</li>
<li><strong>Protein Description:</strong> RecName: Full=Oligodendrocyte transcription factor 2; Short=Oligo2; AltName: Full=Class B basic helix-loop-helix protein 1; Short=bHLHb1; AltName: Full=Class E basic helix-loop-helix protein 19; Short=bHLHe19; AltName: Full=Protein kinase C-binding protein 2; AltName: Full=Protein kinase C-binding protein RACK17;</li>
<li><strong>Gene Information:</strong> Name=OLIG2; Synonyms=BHLHB1, BHLHE19, PRKCBP2, RACK17;</li>
<li><strong>Organism (full):</strong> Homo sapiens (Human).</li>
<li><strong>Protein Family:</strong> Not specified in UniProt</li>
<li><strong>Key Domains:</strong> bHLH_dom. (IPR011598); bHLH_transcription_factors. (IPR050359); HLH_DNA-bd_sf. (IPR036638); Olig2_bHLH. (IPR032658); HLH (PF00010)</li>
</ul>
<h3 id="mandatory-verification-steps">MANDATORY VERIFICATION STEPS:</h3>
<ol>
<li><strong>Check if the gene symbol "OLIG2" matches the protein description above</strong></li>
<li><strong>Verify the organism is correct:</strong> Homo sapiens (Human).</li>
<li><strong>Check if protein family/domains align with what you find in literature</strong></li>
<li><strong>If you find literature for a DIFFERENT gene with the same or similar symbol, STOP</strong></li>
</ol>
<h3 id="if-gene-symbol-is-ambiguous-or-you-cannot-find-relevant-literature">If Gene Symbol is Ambiguous or You Cannot Find Relevant Literature:</h3>
<p><strong>DO NOT PROCEED WITH RESEARCH ON A DIFFERENT GENE.</strong> Instead:<br />
- State clearly: "The gene symbol 'OLIG2' is ambiguous or literature is limited for this specific protein"<br />
- Explain what you found (e.g., "Found extensive literature on a different gene with the same symbol in a different organism")<br />
- Describe the protein based ONLY on the UniProt information provided above<br />
- Suggest that the protein function can be inferred from domain/family information</p>
<h3 id="research-target">Research Target:</h3>
<p>Please provide a comprehensive research report on the gene <strong>OLIG2</strong> (gene ID: OLIG2, UniProt: Q13516) in human.</p>
<p>The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.</p>
<p>You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement<br />
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.</p>
<p>We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.</p>
<p>We are interested in where in or outside the cell the gene product carries out its function.</p>
<p>We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.</p>
<p>Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.</p>
<h2 id="output">Output</h2>
<h1 id="olig2-q13516-oligodendrocyte-transcription-factor-2">OLIG2 (Q13516): Oligodendrocyte Transcription Factor 2</h1>
<h2 id="introduction-and-summary">Introduction and Summary</h2>
<p>OLIG2 (Oligodendrocyte Transcription Factor 2) is a basic helix-loop-helix (bHLH) transcription factor that plays essential roles in the specification of motor neurons and oligodendrocytes in the developing vertebrate central nervous system. The human gene is located on chromosome 21q22.11 and encodes a 329 amino acid protein of approximately 32 kDa [omim-606386]. OLIG2 was identified independently by multiple groups in 2000-2001 as a critical regulator of neural cell fate determination in the ventral spinal cord [zhou-2001-olig2-nkx22-abstract].</p>
<p>The protein contains a single basic helix-loop-helix DNA-binding domain that enables it to bind E-box sequences (CANNTG) in the regulatory regions of target genes. What distinguishes OLIG2 from many other tissue-restricted bHLH factors is its ability to function as both a transcriptional activator and repressor depending on cellular context, phosphorylation state, and dimerization partners [lee-2005-olig2-ngn2-abstract]. This dual functionality allows OLIG2 to orchestrate the sequential generation of motor neurons and oligodendrocytes from a common progenitor pool.</p>
<p>In the embryonic spinal cord, OLIG2 expression marks the pMN (motor neuron progenitor) domain, a restricted region of the ventral ventricular zone induced by Sonic hedgehog (Shh) signaling from the notochord and floor plate. Cells within this domain first generate motor neurons during early embryogenesis (E9-10 in mouse), then switch to producing oligodendrocyte precursor cells (OPCs) at later developmental stages (after E12) [takebayashi-2002-olig2-essential-abstract]. This remarkable temporal switch in cell fate is controlled by reversible phosphorylation of OLIG2 at Serine 147, which modulates its dimerization preferences and cofactor interactions [li-2011-phosphorylation-abstract].</p>
<p>Beyond its developmental roles, OLIG2 has emerged as a clinically significant marker for brain tumors, particularly gliomas and glioblastomas, where it promotes tumor cell proliferation by repressing the cell cycle inhibitor p21 [ligon-2007-olig2-glioma-abstract]. The protein's functions in both normal development and disease have made it a target of considerable research interest for therapeutic applications in demyelinating diseases and brain cancers.</p>
<h2 id="molecular-structure-and-dna-binding-properties">Molecular Structure and DNA Binding Properties</h2>
<p>OLIG2 belongs to the Class B (tissue-restricted) family of bHLH transcription factors. The protein's defining feature is its basic helix-loop-helix domain, which mediates both DNA binding and dimerization. The basic region, located N-terminal to the first helix, makes direct contact with DNA in the major groove, while the two amphipathic helices connected by a variable loop enable protein-protein interactions [elbaz-2019-molecular-control-abstract].</p>
<p>Like other bHLH proteins, OLIG2 recognizes E-box motifs with the core consensus sequence CANNTG. Studies on bHLH transcription factor binding specificity have revealed that the central dinucleotide within the E-box determines which bHLH proteins bind preferentially. OLIG2 appears to belong to the group that favors E-boxes containing CAG half-sites, binding sequences such as CAGCTG. This preference is determined by specific residues in the basic domain that contact the central bases of the E-box [mechanisms-bhlh-2021].</p>
<p>A distinguishing characteristic of OLIG2 is its ability to form stable homodimers, whereas most lineage-restricted bHLH factors require heterodimerization with Class A (ubiquitous) E-proteins such as E47 for DNA binding. Biochemical studies have demonstrated that OLIG2 binds to itself with high affinity, though it can also heterodimerize with E47 and other bHLH proteins including Neurogenin 2 (NGN2), OLIG1, and HES family members [lee-2005-olig2-ngn2-abstract]. The choice of dimerization partner has profound functional consequences: OLIG2 homodimers tend to function as transcriptional repressors, while heterodimers with E47 can activate transcription of target genes such as the Sox10 enhancer [kuspert-2010-sox10-enhancer-abstract].</p>
<p>The phosphorylation state of OLIG2 critically regulates its dimerization preferences. Serine 147, located within the helix-loop-helix domain, is the key regulatory residue. When phosphorylated (likely by protein kinase A), OLIG2 preferentially forms homodimers and is sequestered from interacting with NGN2, allowing NGN2 to homodimerize and drive motor neuron differentiation. When S147 is dephosphorylated, OLIG2 shifts to preferentially forming heterodimers with NGN2 and other partners, sequestering NGN2 from its pro-neural functions and promoting oligodendrocyte fate [li-2011-phosphorylation-abstract]. Additional phosphorylation sites at a triple serine motif (S10, S13, S14) regulate OLIG2's proliferative functions, while phosphorylation at S30 influences the astrocyte versus neuronal progenitor fate decision [elbaz-2019-molecular-control-abstract].</p>
<h2 id="protein-protein-interactions-and-chromatin-regulation">Protein-Protein Interactions and Chromatin Regulation</h2>
<p>Beyond its dimerization partners, OLIG2 interacts with a broader network of transcriptional regulators and chromatin modifying complexes that are essential for its developmental functions. Characterization of OLIG2 interactions using yeast two-hybrid and immunoprecipitation assays has revealed binding to homeodomain transcription factors such as NKX2.2, as well as to ID2 and ID4 helix-loop-helix proteins that act as dominant-negative inhibitors of bHLH function [lee-2005-olig2-ngn2-abstract].</p>
<p>A particularly important interaction involves the ATP-dependent SWI/SNF chromatin-remodeling enzyme SMARCA4/BRG1. Yu et al. (2013) demonstrated that activation of BRG1 at the onset of oligodendrocyte differentiation is necessary and sufficient to initiate and promote oligodendrocyte lineage progression. Critically, OLIG2 functions as a "pre-patterning factor" that directs BRG1 to oligodendrocyte-specific enhancers before differentiation begins [yu-2013-chromatin-remodelers-abstract]. Approximately 71% of BRG1 binding regions contain E-box motifs recognized by OLIG2, and co-immunoprecipitation studies showed that the OLIG2-BRG1 interaction is weak in OPCs but dramatically enhanced during differentiation. This interaction was confirmed at the endogenous level in postnatal mouse brain tissue, establishing the physiological relevance of this complex.</p>
<p>The OLIG2-BRG1 axis exhibits temporal specificity in target gene regulation. Early during differentiation, this complex activates genes such as CNP and MBP, while later targets involve cytoskeletal reorganization genes necessary for myelin sheath formation. The coupling of OLIG2/BRG1 occupancy with activating histone modifications such as H3K27Ac provides a chromatin-based mechanism for stage-specific gene regulation during oligodendrocyte development [yu-2013-chromatin-remodelers-abstract].</p>
<p>Additional chromatin-related functions include OLIG2's recruitment of the histone methyltransferase SETDB1 for H3K9me3 modification. This repressive epigenetic mechanism targets genes like Sox11 that must be silenced during the transition from OPCs to immature oligodendrocytes, representing a non-canonical transcriptional repression function distinct from OLIG2's direct DNA binding activity [nature-comms-2022].</p>
<h2 id="subcellular-localization-and-regulation">Subcellular Localization and Regulation</h2>
<p>OLIG2 functions primarily in the nucleus where it binds DNA and regulates transcription. However, the protein's subcellular localization is dynamically regulated and has significant functional consequences for cell fate determination. In neural stem cells and their neuronal and oligodendroglial progeny, OLIG2 is predominantly nuclear [setoguchi-2004-nuclear-export-abstract]. In contrast, in astrocytes, OLIG2 is found exclusively in the cytoplasm.</p>
<p>The nuclear-to-cytoplasmic translocation of OLIG2 is essential for astrocyte differentiation. Setoguchi and Kondo (2004) demonstrated that when OLIG2 accumulates in the nucleus of neural stem cells, it blocks ciliary neurotrophic factor (CNTF)-induced astrocyte differentiation. The translocation of OLIG2 to the cytoplasm is promoted by activated AKT kinase through the PI3K signaling pathway [setoguchi-2004-nuclear-export-abstract]. OLIG2 contains a putative CRM1/XPO1 nuclear export signal, and mutants lacking this signal are deficient in both CNTF-induced nuclear export and astrocyte differentiation. AKT directly phosphorylates OLIG2, and mutations affecting AKT phosphorylation sites also impair nuclear export.</p>
<p>This mechanism explains why the inactivation or loss of nuclear OLIG2 function is essential for astrocytic differentiation. The cytoplasmic translocation effectively inactivates OLIG2 as a transcriptional regulator, thereby relieving its repression of astrocyte-specific genes and allowing progenitors to respond to gliogenic signals [setoguchi-2004-nuclear-export-abstract].</p>
<p>Regional analysis of the adult mouse brain has revealed surprising heterogeneity in OLIG2 expression among astrocytes. While OLIG2 was initially considered an oligodendrocyte-specific marker, over 80% of astrocytes express OLIG2 in certain brain regions including the olfactory bulb, midbrain, thalamus, medulla, and spinal cord. These OLIG2-positive astrocytes likely represent a functionally distinct subpopulation, underscoring the complexity of glial cell identity [molecular-brain-2021].</p>
<h2 id="role-in-motor-neuron-specification">Role in Motor Neuron Specification</h2>
<p>OLIG2 was originally identified as a key regulator of motor neuron development in the ventral spinal cord. Its expression in the pMN domain is induced by Sonic hedgehog (Shh) signaling, which establishes a gradient of transcription factor expression along the dorsoventral axis. The pMN domain, characterized by OLIG2 expression, lies between the more ventral p3 domain (marked by NKX2.2) and the more dorsal p2 domain. The boundaries of these domains are established through cross-repressive interactions among homeodomain and bHLH transcription factors [takebayashi-2002-olig2-essential-abstract].</p>
<p>The essential requirement for OLIG2 in motor neuron development was dramatically demonstrated by gene knockout studies. Takebayashi et al. (2002) showed that in Olig2-null mice, "motoneurons are largely eliminated and oligodendrocytes are not produced." The mutant neuroepithelial cells failed to differentiate into either cell type and instead expressed the astrocyte marker S100-beta, indicating a fate conversion. This study provided "the first evidence that a single gene mutation leads to the loss of two cell types, motoneuron and oligodendrocyte" [takebayashi-2002-olig2-essential-abstract].</p>
<p>OLIG2 promotes motor neuron development through multiple mechanisms. It triggers the expression of Neurogenin 2 (NGN2) and LHX3, transcription factors that drive the expression of pan-neuronal and motor neuron-specific genes. However, OLIG2 also acts paradoxically to restrain premature differentiation. Lee et al. (2005) discovered that OLIG2 and NGN2 "function in opposition to modulate gene expression in motor neuron progenitor cells" [lee-2005-olig2-ngn2-abstract]. OLIG2 antagonizes the premature expression of post-mitotic motor neuron genes such as HB9 by competing with NGN2 for binding to E-box elements in enhancer regions. When OLIG2 binds as a homodimer to these sites, it displaces NGN2:E47 activator complexes and silences gene expression.</p>
<p>This balance between OLIG2 and NGN2 creates a gate for timing proper gene expression. When OLIG2 levels are high relative to NGN2, progenitors are maintained in a proliferative state. As NGN2 levels rise or OLIG2 activity is modulated (for example, through phosphorylation changes), the balance tips toward motor neuron differentiation [lee-2005-olig2-ngn2-abstract]. Recent single-cell transcriptomic studies have revealed that OLIG2 also controls the rate of motor neuron differentiation through direct repression of HES family transcription factors, which are Notch signaling effectors that promote progenitor maintenance.</p>
<h2 id="role-in-oligodendrocyte-development">Role in Oligodendrocyte Development</h2>
<p>Following the neurogenic phase, OLIG2-expressing progenitors in the pMN domain switch to producing oligodendrocyte precursor cells (OPCs). This switch, occurring around embryonic day 12.5 in mouse, represents one of the most dramatic temporal cell fate transitions in neural development. OLIG2 is not merely permissive but actively required for oligodendrocyte specification and differentiation [zhou-2001-olig2-nkx22-abstract].</p>
<p>The mechanism underlying the motor neuron-to-oligodendrocyte switch is regulated by reversible phosphorylation of OLIG2 at Serine 147. Li et al. (2011) demonstrated that S147 is phosphorylated during motor neuron production and dephosphorylated at the onset of OPC genesis. Phosphorylation promotes OLIG2 homodimerization and favors motor neuron fate, while dephosphorylation allows OLIG2 to heterodimerize with NGN2 and sequester it from pro-neural functions, thereby promoting oligodendrocyte specification [li-2011-phosphorylation-abstract]. Elegant genetic experiments showed that mice expressing OLIG2(S147A), which cannot be phosphorylated, fail to produce motor neurons but retain the capacity to generate oligodendrocytes.</p>
<p>For OPC specification to occur, OLIG2 must cooperate with the homeodomain transcription factor NKX2.2. Zhou et al. (2001) showed that "OLIG2 and NKX2.2 are important determinants of oligodendrocyte differentiation and must be co-expressed as a precondition for differentiation to occur" [zhou-2001-olig2-nkx22-abstract]. When co-expressed, these factors promote ectopic and precocious oligodendrocyte differentiation through repressor mechanisms. This collaboration requires temporal changes in expression patterns: early in development, NKX2.2 is restricted to the more ventral p3 domain, but later it expands dorsally to overlap with OLIG2 expression, enabling the combinatorial specification of OPCs.</p>
<p>Once OPCs are specified, OLIG2 continues to play essential roles in oligodendrocyte maturation and myelination. OLIG2 directly activates expression of SOX10, a transcription factor critical for oligodendrocyte maturation, by binding to the U2 enhancer located approximately 36 kilobases upstream of the Sox10 gene. This activation is most robust when OLIG2 heterodimerizes with the E-protein E47 [kuspert-2010-sox10-enhancer-abstract]. Once induced, SOX10 maintains OLIG2 expression through a positive feedback loop, ensuring continued oligodendrocyte identity.</p>
<p>The mature oligodendrocyte transcriptional network involves coordination among multiple factors: OLIG2, SOX10, NKX2.2, ZFP24, and MYRF. SOX10 activates MYRF (Myelin Gene Regulatory Factor), which then cooperates with SOX10 to drive expression of myelin genes including MBP, PLP1, and others. Interestingly, OLIG2 has been shown to have stage-specific opposing effects on oligodendrocyte maturation. While essential for OPC specification and early differentiation, deletion of Olig2 specifically in differentiating oligodendrocytes actually accelerates their differentiation and myelination, suggesting OLIG2 may restrain terminal differentiation [elbaz-2019-molecular-control-abstract].</p>
<p>Recent work has uncovered a non-canonical function of OLIG2 in transcriptional repression during myelinogenesis. OLIG2 recruits the histone methyltransferase SETDB1 for H3K9me3 modification on the Sox11 gene, leading to inhibition of Sox11 expression during OPC differentiation into immature oligodendrocytes. This represents an epigenetic mechanism by which OLIG2 modulates the myelination program [nature-comms-2022].</p>
<h2 id="relationship-between-olig1-and-olig2">Relationship Between OLIG1 and OLIG2</h2>
<p>OLIG2 is closely related to OLIG1, another bHLH transcription factor that shares significant sequence homology and overlapping expression patterns in the CNS. Despite their structural similarity and coordinated expression, these proteins exhibit distinct biological functions that are only partially redundant [meijer-2012-olig1-olig2-divergence-abstract].</p>
<p>OLIG2 functions primarily at early developmental stages, opposing cell differentiation and sustaining the replication-competent state to expand the progenitor pool. It subsequently promotes the fate choice decision to form early oligodendrocyte progenitors and motor neurons. In contrast, OLIG1 specializes in oligodendrocyte maturation and differentiation, with its critical role emerging at the onset of myelination. Olig1 knockout mice produce early-stage oligodendrocytes with complex branching morphologies that fail to myelinate [meijer-2012-olig1-olig2-divergence-abstract].</p>
<p>Molecular distinctions between OLIG1 and OLIG2 include their subcellular localization dynamics. OLIG2 maintains nuclear localization throughout all developmental stages, while OLIG1 undergoes nuclear-to-cytoplasm relocalization during oligodendrocyte terminal differentiation. This translocation marks the final stages of maturation [meijer-2012-olig1-olig2-divergence-abstract]. The two factors also differ in their transcriptional activities: OLIG2 operates primarily as a transcriptional repressor, binding E-box elements in genes like HB9 to prevent premature differentiation, while OLIG1 directly activates myelin genes including MBP, MOG, and PLP1, often in cooperation with SOX10.</p>
<p>Despite these differences, OLIG1 and OLIG2 exhibit partial redundancy. In OLIG2-null mice, some OPCs persist in the brain, but no OPCs are found in OLIG1/OLIG2 compound nulls, indicating that OLIG1 can partially compensate for OLIG2 loss specifically in the brain [meijer-2012-olig1-olig2-divergence-abstract]. Interestingly, regional differences in the Olig1-null phenotype may be partially attributed to compensatory upregulation of OLIG2 in the spinal cord, which is not observed in the brain. This demonstrates a unique role for OLIG1 in promoting oligodendrocyte commitment primarily in the brain.</p>
<p>Post-translational modifications also differ between the two proteins. While OLIG2 S147 phosphorylation regulates the motor neuron-oligodendrocyte switch, OLIG1 has a corresponding serine at position 138 that may serve analogous regulatory functions. The two proteins also have distinct co-regulator associations: OLIG2 interacts with the histone acetyltransferase p300, while OLIG1 specifically interacts with CCNDBP1 to modulate TGF-beta signaling [meijer-2012-olig1-olig2-divergence-abstract].</p>
<h2 id="evolutionary-conservation">Evolutionary Conservation</h2>
<p>The OLIG gene family has an ancient evolutionary origin and remarkable conservation across vertebrates, reflecting the fundamental importance of these transcription factors in neural development. Li and Richardson (2008) proposed that two rounds of whole genome duplication during early vertebrate evolution generated OLIG2, OLIG3, and OLIG4 from a single ancestral gene, while OLIG1 arose through local duplication at the OLIG2 locus with recombination from another bHLH gene [li-2008-olig-evolution-abstract].</p>
<p>Genome-wide database searches have identified orthologs across diverse species. OLIG1/2/3 are present in mammals, amphibians, and teleost fish, while OLIG4 is found only in teleosts and amphibians. In Drosophila melanogaster, a single family member called Oli (Olig family) represents the ancestral state before vertebrate gene duplications. Importantly, overexpression of vertebrate OLIG2 can partially rescue walking defects in Oli-deficient flies, demonstrating conserved function across more than 500 million years of evolution [li-2008-olig-evolution-abstract].</p>
<p>Studies in zebrafish have confirmed conserved roles of OLIG2 in motor neuron and oligodendrocyte development. As in mammals, oligodendrocytes in zebrafish arise from the motoneuron progenitor (pMN) domain of the ventral spinal cord, where motoneurons form first and oligodendrocytes develop later. Loss-of-function studies demonstrate that zebrafish olig2 is required for primary motor neuron development, paralleling findings in mouse [li-2008-olig-evolution-abstract].</p>
<p>The evolution of myelin, a defining feature of jawed vertebrates that emerged approximately 400 million years ago, appears to have paralleled OLIG gene evolution. A putative MBP ancestor in the lancelet (Branchiostoma floridae), a non-myelinating organism, lacks the conserved binding sites for OLIG1 and SOX10 that are present in vertebrate myelin genes. This suggests that acquisition of OLIG/SOX10 binding sites in myelin gene regulatory regions was a critical evolutionary innovation enabling the genetic program for CNS myelination [li-2008-olig-evolution-abstract].</p>
<p>Analysis of the OLIG2 promoter has revealed ultraconserved elements with high sequence identity across seventeen vertebrate species from fish to mammals. These highly conserved non-coding elements likely contain critical regulatory sequences that ensure proper temporal and spatial OLIG2 expression, reflecting strong evolutionary pressure to maintain precise developmental control [li-2008-olig-evolution-abstract].</p>
<h2 id="signaling-pathways-and-upstream-regulation">Signaling Pathways and Upstream Regulation</h2>
<p>The expression and activity of OLIG2 are regulated by multiple signaling pathways that control neural development. The primary inducer of OLIG2 expression is Sonic hedgehog (Shh), a secreted morphogen produced by the notochord and floor plate. Shh establishes a ventral-to-dorsal gradient in the developing neural tube, and the concentration of Shh signaling determines which transcription factors are expressed in each progenitor domain. In the pMN domain, Shh signaling induces OLIG2 expression while repressing factors such as IRX3 and PAX6 that mark more dorsal domains.</p>
<p>The requirement for Shh signaling in OLIG2 induction has been demonstrated in multiple systems. In the absence of NKX6 genes or Shh signaling, the initial expression of OLIG2 in the pMN domain is completely abolished [lee-2005-olig2-ngn2-abstract]. Shh signaling acts through the GLI family of transcription factors, which directly bind to regulatory elements in the OLIG2 gene.</p>
<p>Beyond Shh, Notch signaling also regulates OLIG2 function. Notch promotes the progenitor state and inhibits premature differentiation. Marumo et al. (2013) showed that inhibition of Notch signaling prevents the nuclear translocation of OLIG2 and the proliferation of reactive astrocytes. The interplay between Notch and OLIG2 involves HES transcription factors, which are Notch effectors that OLIG2 can directly repress [setoguchi-2004-nuclear-export-abstract].</p>
<p>OLIG2 activity is also modulated by multiple kinases that phosphorylate specific residues. As discussed above, phosphorylation at S147 (likely by protein kinase A) regulates the motor neuron-oligodendrocyte switch. The triple serine motif at S10, S13, and S14 is targeted by multiple kinases: GSK3-beta phosphorylates S10, CDK1/CDK2 phosphorylate S14, and CK2 phosphorylates S13. These modifications regulate OLIG2's proliferative functions [elbaz-2019-molecular-control-abstract]. Phosphorylation at S30, regulated by AKT, determines whether cortical progenitor cells differentiate into astrocytes or remain as neuronal progenitors.</p>
<p>The calcineurin-NFAT pathway provides another layer of regulation. Calcineurin-mediated activation of NFATC2 allows for co-expression of OLIG2 and NKX2.2, initiating oligodendrocyte differentiation. The chromatin remodelers CHD8 and BRG1 form a complex with OLIG2 on chromatin, and this CHD8-BRG1-OLIG2 axis promotes oligodendrocyte differentiation [elbaz-2019-molecular-control-abstract].</p>
<h2 id="disease-implications">Disease Implications</h2>
<h3 id="gliomas-and-glioblastoma">Gliomas and Glioblastoma</h3>
<p>OLIG2 has emerged as a clinically significant marker for brain tumors, particularly diffuse gliomas and glioblastoma multiforme (GBM). While OLIG2 expression is normally restricted to the central nervous system, it is universally expressed in all diffuse gliomas (astrocytomas, oligodendrogliomas, and oligoastrocytomas) and in nearly 100% of glioma cancer stem cells [ligon-2007-olig2-glioma-abstract][ligon-2004-olig2-glioma-marker-abstract]. This makes OLIG2 both a diagnostic marker and a potential therapeutic target.</p>
<p>The clinical utility of OLIG2 immunohistochemistry has been validated in large studies. Analysis of 180 primary, metastatic, and non-neural human tumors demonstrates that OLIG2 is a useful positive diagnostic marker for diffuse gliomas. Because OLIG2 has nuclear expression, it is often considerably easier to interpret than cytoplasmic markers such as GFAP, which produces background parenchymal staining [ligon-2004-olig2-glioma-marker-abstract]. OLIG2 expression is inconsistent and generally lower in other brain tumor types and is absent in non-neuroectodermal tumors. However, expression heterogeneity in astrocytomas precludes immunohistochemical classification of individual glioma subtypes by OLIG2 alone.</p>
<p>Recent molecular profiling has examined OLIG2 expression in relation to IDH mutation status. While OLIG2 is expressed in both IDH-mutant lower-grade gliomas and IDH-wildtype glioblastomas, expression levels differ. OLIG2 overexpression serves as a reasonable surrogate marker for IDH mutation (AUC = 0.90) but predicts poorly for 1p/19q co-deletion, the class-defining alteration for oligodendroglioma [ligon-2004-olig2-glioma-marker-abstract].</p>
<p>The functional importance of OLIG2 in gliomagenesis was established by Ligon et al. (2007), who demonstrated that "Olig2 function is required for proliferation of neural progenitors and for glioma formation." The mechanistic basis for this requirement involves OLIG2's direct repression of the cell cycle inhibitor p21 (CDKN1A). OLIG2 binds to E-box elements in the p21 promoter and suppresses its expression, promoting cell cycle progression [ligon-2007-olig2-glioma-abstract]. Loss of OLIG2 function leads to p21 upregulation, reduced proliferation, and morphological changes toward differentiation.</p>
<p>Importantly, genetic knockdown of OLIG2 inhibits the ability of human glioma stem cells to form intracranial tumors, suggesting OLIG2 is required for tumor maintenance as well as initiation. Flow cytometry analysis of fresh human glioblastomas shows that CD133+ tumor-initiating cells are almost universally OLIG2-positive (98%), and immunohistochemical studies reveal that approximately 85% of Ki67+ proliferating glioma cells express OLIG2 [ligon-2007-olig2-glioma-abstract]. Comparative microarray analysis has identified OLIG2 as the most specific glioblastoma stem cell marker, with the highest differential expression between GSC-enriched and differentiated tumor cell cultures.</p>
<p>These findings have stimulated interest in developing OLIG2 inhibitors for glioblastoma therapy. CT-179, an OLIG2 chemical inhibitor, has shown in vitro efficacy against pediatric GBM samples and is well tolerated in vivo when combined with radiation therapy. However, challenges remain in pharmacologically targeting transcription factors, which lack enzymatic active sites and are traditionally considered "undruggable."</p>
<h3 id="demyelinating-diseases">Demyelinating Diseases</h3>
<p>Given OLIG2's essential role in oligodendrocyte development and myelination, there has been considerable interest in its potential as a therapeutic target for demyelinating diseases such as multiple sclerosis (MS). Wegrzyn et al. (2015) demonstrated that overexpression of OLIG2 in OPCs enhances their migration and differentiation, leading to accelerated remyelination in animal models [wegrzyn-2015-remyelination-abstract].</p>
<p>In a focal demyelination model using lysophosphatidylcholine injection into the corpus callosum, transgenic mice with inducible OLIG2 overexpression showed significantly higher percentages of remyelinated axons at 7 and 14 days post-injection compared to controls. OLIG2 overexpression enhanced expression of myelin-related genes including MYRF, MBP, and PLP1 [wegrzyn-2015-remyelination-abstract].</p>
<p>Analysis of post-mortem MS brain tissue has revealed differential OLIG2 expression patterns that correlate with lesion activity. OLIG2 shows highest expression in active lesions compared to chronic silent lesions and normal-appearing white matter. Notably, OLIG2 localizes predominantly to maturing oligodendrocytes (NOGO-A positive) in active lesion borders rather than to early progenitor cells, suggesting OLIG2 may promote the later stages of remyelination [wegrzyn-2015-remyelination-abstract]. In chronic MS, both mature oligodendrocytes and OLIG2+ OPCs are significantly reduced in cortical lesions, indicating failure of the regenerative response.</p>
<p>Therapeutic strategies to enhance OLIG2 function for remyelination remain challenging. Approaches under investigation include small agonists of the Sonic hedgehog signaling pathway that might enhance OLIG2 expression, and the development of stapled peptides that could modulate OLIG2 interactions with cofactors [wegrzyn-2015-remyelination-abstract].</p>
<h3 id="other-disease-associations">Other Disease Associations</h3>
<p>Genetic variants in OLIG2 have been associated with susceptibility to schizophrenia in multiple studies, with SNPs rs1059004 and rs762178 showing significant associations in patient cohorts. These associations may reflect OLIG2's role in oligodendrocyte development and myelination, as white matter abnormalities are frequently observed in schizophrenia [omim-606386].</p>
<p>A chromosomal translocation t(14;21)(q11.2;q22) that activates aberrant OLIG2 expression in T-cells has been identified in T-cell acute lymphoblastic leukemia (T-ALL), demonstrating that OLIG2 can have oncogenic roles outside its normal CNS expression domain [omim-606386].</p>
<h2 id="open-questions">Open Questions</h2>
<p>Despite significant advances in understanding OLIG2 function, several important questions remain:</p>
<ol>
<li>
<p><strong>Structural biology</strong>: High-resolution structures of OLIG2 in complex with different dimerization partners and DNA targets would illuminate how phosphorylation and cofactor choice alter its transcriptional activity. Such structures could also guide development of therapeutic modulators.</p>
</li>
<li>
<p><strong>Phosphorylation dynamics</strong>: While the importance of S147 phosphorylation is established, the precise kinases and phosphatases that regulate this modification in vivo, and how their activities are temporally controlled during the MN-OPC switch, remain incompletely understood.</p>
</li>
<li>
<p><strong>Non-canonical functions</strong>: The recently discovered role of OLIG2 in recruiting histone modifying enzymes like SETDB1 suggests additional epigenetic mechanisms beyond direct DNA binding. The full scope of OLIG2's chromatin regulatory functions awaits further investigation.</p>
</li>
<li>
<p><strong>Regional heterogeneity</strong>: The discovery of OLIG2-expressing astrocyte subpopulations in specific brain regions raises questions about how OLIG2 functions in these cells and whether it contributes to astrocyte regional identity or specialized functions.</p>
</li>
<li>
<p><strong>Therapeutic targeting</strong>: How can OLIG2 activity be specifically enhanced for remyelination therapies while avoiding potential pro-tumorigenic effects? Conversely, how can OLIG2 be safely inhibited in gliomas without disrupting normal oligodendrocyte function?</p>
</li>
<li>
<p><strong>Activity-dependent regulation</strong>: The role of neuronal activity in modulating OLIG2 function and oligodendrocyte responses remains an emerging area. Understanding how activity-dependent signals influence OLIG2 could have implications for adaptive myelination.</p>
</li>
<li>
<p><strong>Human-specific functions</strong>: While most mechanistic studies have been performed in mouse models, validation in human cells and tissues is critical for therapeutic development. The extent to which mouse findings translate to human OLIG2 biology deserves continued attention.</p>
</li>
</ol>
<h2 id="references">References</h2>
<ul>
<li>
<p>[zhou-2001-olig2-nkx22-abstract] Zhou Q, Choi G, Anderson DJ. The bHLH transcription factor Olig2 promotes oligodendrocyte differentiation in collaboration with Nkx2.2. Neuron. 2001 Sep 13;31(5):791-807. PMID: 11567617. DOI: 10.1016/s0896-6273(01)00414-7. https://pubmed.ncbi.nlm.nih.gov/11567617/</p>
</li>
<li>
<p>[takebayashi-2002-olig2-essential-abstract] Takebayashi H, Nabeshima Y, Yoshida S, Chisaka O, Ikenaka K, Nabeshima Y. The basic helix-loop-helix factor olig2 is essential for the development of motoneuron and oligodendrocyte lineages. Curr Biol. 2002 Jul 9;12(13):1157-63. PMID: 12121626. DOI: 10.1016/s0960-9822(02)00926-0. https://pubmed.ncbi.nlm.nih.gov/12121626/</p>
</li>
<li>
<p>[li-2011-phosphorylation-abstract] Li H, Paes de Faria J, Andrew P, Nitarska J, Richardson WD. Phosphorylation regulates OLIG2 cofactor choice and the motor neuron-oligodendrocyte fate switch. Neuron. 2011 Mar 10;69(5):918-29. PMID: 21382552. DOI: 10.1016/j.neuron.2011.01.030. https://pubmed.ncbi.nlm.nih.gov/21382552/</p>
</li>
<li>
<p>[lee-2005-olig2-ngn2-abstract] Lee SK, Lee B, Ruiz EC, Pfaff SL. Olig2 and Ngn2 function in opposition to modulate gene expression in motor neuron progenitor cells. Genes Dev. 2005 Jan 15;19(2):282-94. DOI: 10.1101/gad.1257105. PMCID: PMC545894. https://pmc.ncbi.nlm.nih.gov/articles/PMC545894/</p>
</li>
<li>
<p>[ligon-2007-olig2-glioma-abstract] Ligon KL, Huillard E, et al. Olig2-regulated lineage-restricted pathway controls replication competence in neural stem cells and malignant glioma. Neuron. 2007 Feb 15;53(4):503-17. PMID: 17296553. DOI: 10.1016/j.neuron.2007.01.009. PMCID: PMC1810344. https://pmc.ncbi.nlm.nih.gov/articles/PMC1810344/</p>
</li>
<li>
<p>[setoguchi-2004-nuclear-export-abstract] Setoguchi T, Kondo T. Nuclear export of OLIG2 in neural stem cells is essential for ciliary neurotrophic factor-induced astrocyte differentiation. J Cell Biol. 2004 Sep 27;166(7):963-8. PMID: 15452140. DOI: 10.1083/jcb.200404104. PMCID: PMC2172021. https://pubmed.ncbi.nlm.nih.gov/15452140/</p>
</li>
<li>
<p>[elbaz-2019-molecular-control-abstract] Elbaz B, Popko B. Molecular Control of Oligodendrocyte Development. Trends Neurosci. 2019 Apr;42(4):263-277. DOI: 10.1016/j.tins.2019.01.002. PMCID: PMC7397568. https://pmc.ncbi.nlm.nih.gov/articles/PMC7397568/</p>
</li>
<li>
<p>[kuspert-2010-sox10-enhancer-abstract] K√ºspert M, Hammer A, B√∂sl MR, Wegner M. Olig2 regulates Sox10 expression in oligodendrocyte precursors through an evolutionary conserved distal enhancer. Nucleic Acids Res. 2011 Feb;39(4):1280-93. DOI: 10.1093/nar/gkq951. PMCID: PMC3045606. https://pmc.ncbi.nlm.nih.gov/articles/PMC3045606/</p>
</li>
<li>
<p>[wegrzyn-2015-remyelination-abstract] Wegrzyn D, et al. Gain of Olig2 function in oligodendrocyte progenitors promotes remyelination. Brain. 2015 Jan;138(1):120-35. PMID: 25564492. DOI: 10.1093/brain/awu375. PMCID: PMC4441088. https://pmc.ncbi.nlm.nih.gov/articles/PMC4441088/</p>
</li>
<li>
<p>[omim-606386] OMIM Entry 606386 - Oligodendrocyte Lineage Transcription Factor 2; OLIG2. https://omim.org/entry/606386</p>
</li>
<li>
<p>[mechanisms-bhlh-2021] Mechanisms of Binding Specificity among bHLH Transcription Factors. Int J Mol Sci. 2021;22(17):9150. PMID: 34502060. PMCID: PMC8431614. https://pmc.ncbi.nlm.nih.gov/articles/PMC8431614/</p>
</li>
<li>
<p>[nature-comms-2022] The Oligodendrocyte Transcription Factor 2 OLIG2 regulates transcriptional repression during myelinogenesis in rodents. Nat Commun. 2022. PMID: 35301318. https://www.nature.com/articles/s41467-022-29068-z</p>
</li>
<li>
<p>[molecular-brain-2021] Region-specific distribution of Olig2-expressing astrocytes in adult mouse brain and spinal cord. Mol Brain. 2021. https://molecularbrain.biomedcentral.com/articles/10.1186/s13041-021-00747-0</p>
</li>
<li>
<p>[meijer-2012-olig1-olig2-divergence-abstract] Meijer DH, Kane MF, Mehta S, et al. Separated at birth? The functional and molecular divergence of OLIG1 and OLIG2. Nat Rev Neurosci. 2012 Dec;13(12):819-31. DOI: 10.1038/nrn3386. PMCID: PMC3733228. https://pmc.ncbi.nlm.nih.gov/articles/PMC3733228/</p>
</li>
<li>
<p>[yu-2013-chromatin-remodelers-abstract] Yu Y, Lu QR, et al. Olig2 Targets Chromatin Remodelers To Enhancers To Initiate Oligodendrocyte Differentiation. Cell. 2013 Jan 17;152(1-2):248-61. PMID: 23332759. DOI: 10.1016/j.cell.2012.12.006. PMCID: PMC3553550. https://pmc.ncbi.nlm.nih.gov/articles/PMC3553550/</p>
</li>
<li>
<p>[li-2008-olig-evolution-abstract] Li H, Richardson WD. The evolution of Olig genes and their roles in myelination. Neuron Glia Biol. 2008 May;4(2):129-35. PMID: 19737433. PMCID: PMC6326352. https://pmc.ncbi.nlm.nih.gov/articles/PMC6326352/</p>
</li>
<li>
<p>[ligon-2004-olig2-glioma-marker-abstract] Ligon KL, et al. The oligodendroglial lineage marker OLIG2 is universally expressed in diffuse gliomas. J Neuropathol Exp Neurol. 2004 May;63(5):499-509. PMID: 15198128. https://academic.oup.com/jnen/article/63/5/499/1844614</p>
</li>
</ul>
<h2 id="citations">Citations</h2>
<ol>
<li>elbaz-2019-molecular-control-abstract.md</li>
<li>kuspert-2010-sox10-enhancer-abstract.md</li>
<li>lee-2005-olig2-ngn2-abstract.md</li>
<li>li-2008-olig-evolution-abstract.md</li>
<li>li-2011-phosphorylation-abstract.md</li>
<li>ligon-2004-olig2-glioma-marker-abstract.md</li>
<li>ligon-2007-olig2-glioma-abstract.md</li>
<li>mechanisms-bhlh-2021-abstract.md</li>
<li>meijer-2012-olig1-olig2-divergence-abstract.md</li>
<li>nature-comms-2022-olig2-repression-abstract.md</li>
<li>omim-606386-summary.md</li>
<li>setoguchi-2004-nuclear-export-abstract.md</li>
<li>takebayashi-2002-olig2-essential-abstract.md</li>
<li>wegrzyn-2015-remyelination-abstract.md</li>
<li>yu-2013-chromatin-remodelers-abstract.md</li>
<li>zhou-2001-olig2-nkx22-abstract.md</li>
</ol>
            </div>
        </details>
        
        <details class="markdown-section">
            <summary style="display: flex; justify-content: space-between; align-items: center; cursor: pointer;">
                <div style="flex: 1;">
                    <h3 style="display: inline;">Deep Research Falcon</h3>
                    <span style="font-size: 0.8rem; color: #666; margin-left: 1rem;">(OLIG2-deep-research-falcon.md)</span>
                </div>
                <div class="vote-buttons" data-g="Q13516" data-a="DOC: Deep Research Falcon" data-r="" data-act="DOCUMENTATION" style="display: flex; gap: 0.25rem;">
                    <button class="vote-btn" data-v="up" title="This documentation is helpful">üëç</button>
                    <button class="vote-btn" data-v="down" title="This documentation needs improvement">üëé</button>
                </div>
            </summary>
            <div class="markdown-content">
                <hr />
<p>provider: falcon<br />
model: Edison Scientific Literature<br />
cached: false<br />
start_time: '2026-01-11T17:44:47.308011'<br />
end_time: '2026-01-11T17:51:19.742543'<br />
duration_seconds: 392.43<br />
template_file: templates/gene_research_go_focused.md<br />
template_variables:<br />
  organism: human<br />
  gene_id: OLIG2<br />
  gene_symbol: OLIG2<br />
  uniprot_accession: Q13516<br />
  protein_description: 'RecName: Full=Oligodendrocyte transcription factor 2; Short=Oligo2;<br />
    AltName: Full=Class B basic helix-loop-helix protein 1; Short=bHLHb1; AltName:<br />
    Full=Class E basic helix-loop-helix protein 19; Short=bHLHe19; AltName: Full=Protein<br />
    kinase C-binding protein 2; AltName: Full=Protein kinase C-binding protein RACK17;'<br />
  gene_info: Name=OLIG2; Synonyms=BHLHB1, BHLHE19, PRKCBP2, RACK17;<br />
  organism_full: Homo sapiens (Human).<br />
  protein_family: Not specified in UniProt<br />
  protein_domains: bHLH_dom. (IPR011598); bHLH_transcription_factors. (IPR050359);<br />
    HLH_DNA-bd_sf. (IPR036638); Olig2_bHLH. (IPR032658); HLH (PF00010)<br />
provider_config:<br />
  timeout: 600<br />
  max_retries: 3<br />
  parameters:<br />
    allowed_domains: []<br />
    temperature: 0.1<br />
citation_count: 18</p>
<hr />
<h2 id="question">Question</h2>
<h1 id="gene-research-for-functional-annotation">Gene Research for Functional Annotation</h1>
<h2 id="critical-geneprotein-identification-context">‚ö†Ô∏è CRITICAL: Gene/Protein Identification Context</h2>
<p><strong>BEFORE YOU BEGIN RESEARCH:</strong> You MUST verify you are researching the CORRECT gene/protein. Gene symbols can be ambiguous, especially for less well-characterized genes from non-model organisms.</p>
<h3 id="target-geneprotein-identity-from-uniprot">Target Gene/Protein Identity (from UniProt):</h3>
<ul>
<li><strong>UniProt Accession:</strong> Q13516</li>
<li><strong>Protein Description:</strong> RecName: Full=Oligodendrocyte transcription factor 2; Short=Oligo2; AltName: Full=Class B basic helix-loop-helix protein 1; Short=bHLHb1; AltName: Full=Class E basic helix-loop-helix protein 19; Short=bHLHe19; AltName: Full=Protein kinase C-binding protein 2; AltName: Full=Protein kinase C-binding protein RACK17;</li>
<li><strong>Gene Information:</strong> Name=OLIG2; Synonyms=BHLHB1, BHLHE19, PRKCBP2, RACK17;</li>
<li><strong>Organism (full):</strong> Homo sapiens (Human).</li>
<li><strong>Protein Family:</strong> Not specified in UniProt</li>
<li><strong>Key Domains:</strong> bHLH_dom. (IPR011598); bHLH_transcription_factors. (IPR050359); HLH_DNA-bd_sf. (IPR036638); Olig2_bHLH. (IPR032658); HLH (PF00010)</li>
</ul>
<h3 id="mandatory-verification-steps">MANDATORY VERIFICATION STEPS:</h3>
<ol>
<li><strong>Check if the gene symbol "OLIG2" matches the protein description above</strong></li>
<li><strong>Verify the organism is correct:</strong> Homo sapiens (Human).</li>
<li><strong>Check if protein family/domains align with what you find in literature</strong></li>
<li><strong>If you find literature for a DIFFERENT gene with the same or similar symbol, STOP</strong></li>
</ol>
<h3 id="if-gene-symbol-is-ambiguous-or-you-cannot-find-relevant-literature">If Gene Symbol is Ambiguous or You Cannot Find Relevant Literature:</h3>
<p><strong>DO NOT PROCEED WITH RESEARCH ON A DIFFERENT GENE.</strong> Instead:<br />
- State clearly: "The gene symbol 'OLIG2' is ambiguous or literature is limited for this specific protein"<br />
- Explain what you found (e.g., "Found extensive literature on a different gene with the same symbol in a different organism")<br />
- Describe the protein based ONLY on the UniProt information provided above<br />
- Suggest that the protein function can be inferred from domain/family information</p>
<h3 id="research-target">Research Target:</h3>
<p>Please provide a comprehensive research report on the gene <strong>OLIG2</strong> (gene ID: OLIG2, UniProt: Q13516) in human.</p>
<p>The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.</p>
<p>You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement<br />
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.</p>
<p>We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.</p>
<p>We are interested in where in or outside the cell the gene product carries out its function.</p>
<p>We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.</p>
<p>Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.</p>
<h2 id="output">Output</h2>
<p>Question: You are an expert researcher providing comprehensive, well-cited information.</p>
<p>Provide detailed information focusing on:<br />
1. Key concepts and definitions with current understanding<br />
2. Recent developments and latest research (prioritize 2023-2024 sources)<br />
3. Current applications and real-world implementations<br />
4. Expert opinions and analysis from authoritative sources<br />
5. Relevant statistics and data from recent studies</p>
<p>Format as a comprehensive research report with proper citations. Include URLs and publication dates where available.<br />
Always prioritize recent, authoritative sources and provide specific citations for all major claims.</p>
<h1 id="gene-research-for-functional-annotation_1">Gene Research for Functional Annotation</h1>
<h2 id="critical-geneprotein-identification-context_1">‚ö†Ô∏è CRITICAL: Gene/Protein Identification Context</h2>
<p><strong>BEFORE YOU BEGIN RESEARCH:</strong> You MUST verify you are researching the CORRECT gene/protein. Gene symbols can be ambiguous, especially for less well-characterized genes from non-model organisms.</p>
<h3 id="target-geneprotein-identity-from-uniprot_1">Target Gene/Protein Identity (from UniProt):</h3>
<ul>
<li><strong>UniProt Accession:</strong> Q13516</li>
<li><strong>Protein Description:</strong> RecName: Full=Oligodendrocyte transcription factor 2; Short=Oligo2; AltName: Full=Class B basic helix-loop-helix protein 1; Short=bHLHb1; AltName: Full=Class E basic helix-loop-helix protein 19; Short=bHLHe19; AltName: Full=Protein kinase C-binding protein 2; AltName: Full=Protein kinase C-binding protein RACK17;</li>
<li><strong>Gene Information:</strong> Name=OLIG2; Synonyms=BHLHB1, BHLHE19, PRKCBP2, RACK17;</li>
<li><strong>Organism (full):</strong> Homo sapiens (Human).</li>
<li><strong>Protein Family:</strong> Not specified in UniProt</li>
<li><strong>Key Domains:</strong> bHLH_dom. (IPR011598); bHLH_transcription_factors. (IPR050359); HLH_DNA-bd_sf. (IPR036638); Olig2_bHLH. (IPR032658); HLH (PF00010)</li>
</ul>
<h3 id="mandatory-verification-steps_1">MANDATORY VERIFICATION STEPS:</h3>
<ol>
<li><strong>Check if the gene symbol "OLIG2" matches the protein description above</strong></li>
<li><strong>Verify the organism is correct:</strong> Homo sapiens (Human).</li>
<li><strong>Check if protein family/domains align with what you find in literature</strong></li>
<li><strong>If you find literature for a DIFFERENT gene with the same or similar symbol, STOP</strong></li>
</ol>
<h3 id="if-gene-symbol-is-ambiguous-or-you-cannot-find-relevant-literature_1">If Gene Symbol is Ambiguous or You Cannot Find Relevant Literature:</h3>
<p><strong>DO NOT PROCEED WITH RESEARCH ON A DIFFERENT GENE.</strong> Instead:<br />
- State clearly: "The gene symbol 'OLIG2' is ambiguous or literature is limited for this specific protein"<br />
- Explain what you found (e.g., "Found extensive literature on a different gene with the same symbol in a different organism")<br />
- Describe the protein based ONLY on the UniProt information provided above<br />
- Suggest that the protein function can be inferred from domain/family information</p>
<h3 id="research-target_1">Research Target:</h3>
<p>Please provide a comprehensive research report on the gene <strong>OLIG2</strong> (gene ID: OLIG2, UniProt: Q13516) in human.</p>
<p>The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.</p>
<p>You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement<br />
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.</p>
<p>We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.</p>
<p>We are interested in where in or outside the cell the gene product carries out its function.</p>
<p>We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.</p>
<p>Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.</p>
<p>Plan summary<br />
- Verified identity: OLIG2 (UniProt Q13516) is the human basic helix‚Äìloop‚Äìhelix (bHLH) transcription factor ‚ÄúOligodendrocyte transcription factor 2,‚Äù also referred to as BHLHB1/bHLHe19; literature consistently treats OLIG2 as a CNS-restricted lineage TF for oligodendroglia, aligning with UniProt‚Äôs bHLH domain annotations. No symbol ambiguity was detected in the recent literature surveyed. (Szu 2023, Frontiers in Neuroscience, May 2023; https://doi.org/10.3389/fnins.2023.1129434) (szu2023biologicalfunctionsof pages 8-9, szu2023biologicalfunctionsof pages 7-8)</p>
<p>Research report: OLIG2 (human; UniProt Q13516)</p>
<p>1) Key concepts and definitions with current understanding<br />
- Identity and domains: OLIG2 is a Class B/E basic helix‚Äìloop‚Äìhelix transcription factor that binds E-box DNA motifs to regulate lineage programs. It marks oligodendroglial lineage cells in development and adult CNS and is widely expressed in diffuse gliomas. Its bHLH domain and DNA-binding function match the UniProt domain annotations provided. (Frontiers in Neuroscience; May 2023; https://doi.org/10.3389/fnins.2023.1129434) (szu2023biologicalfunctionsof pages 7-8)<br />
- Cellular localization: OLIG2 protein is primarily nuclear in oligodendroglial cells and gliomas, supporting a role as a transcriptional regulator. Anti-human OLIG2 antibodies are widely used in immunohistochemistry (IHC) with nuclear staining patterns in gliomas. (Frontiers in Neuroscience; May 2023; https://doi.org/10.3389/fnins.2023.1129434) (szu2023biologicalfunctionsof pages 3-4, szu2023biologicalfunctionsof pages 8-8)<br />
- Core molecular functions: OLIG2 orchestrates neuron‚Äìglia fate decisions and is required for oligodendrocyte precursor cell (OPC) specification and oligodendrocyte differentiation. Mechanistically, OLIG2 acts as a lineage- and cell-cycle regulator, repressing p21 and antagonizing p53 acetylation to support replication competence in neural stem/progenitor cells and malignant glioma. (Frontiers in Neuroscience; May 2023; https://doi.org/10.3389/fnins.2023.1129434) (szu2023biologicalfunctionsof pages 4-5)<br />
- Partner transcription factors and complexes: Functional partners include ASCL1, SOX10, and NKX2.2 in the oligodendroglial gene regulatory network. In glioblastoma (GBM), OLIG2 and ASCL1 co-occupy each other‚Äôs loci and extensively co-bind downstream targets, jointly shaping tumor cell states and migration. (Nature Communications; Nov 2024; https://doi.org/10.1038/s41467-024-54750-9) (myers2024transcriptionfactorsascl1 pages 1-2, myers2024transcriptionfactorsascl1 pages 14-15)<br />
- Upstream signaling pathways: OLIG2 is induced by Sonic hedgehog (Shh) and participates in cross-talk with FGF and EGFR receptor tyrosine kinase signaling; Notch activity is linked to nucleocytoplasmic dynamics of OLIG2 in reactive astrocytes and to stem-like behavior in gliomas. (Frontiers in Neuroscience; May 2023; https://doi.org/10.3389/fnins.2023.1129434) (szu2023biologicalfunctionsof pages 3-4, szu2023biologicalfunctionsof pages 4-5, szu2023biologicalfunctionsof pages 8-8)<br />
- Post-translational regulation: Phosphorylation of OLIG2 modulates intranuclear compartmentalization and fate outcomes (e.g., a serine-rich N-terminal motif; phosphorylation state linked to proliferation vs differentiation decisions). Notch-dependent control of nucleocytoplasmic translocation has been reported in astroglial contexts. (Frontiers in Neuroscience; May 2023; https://doi.org/10.3389/fnins.2023.1129434) (szu2023biologicalfunctionsof pages 8-9, szu2023biologicalfunctionsof pages 8-8)</p>
<p>2) Recent developments and latest research (prioritized 2023‚Äì2024)<br />
- ASCL1‚ÄìOLIG2 co-regulation in GBM initiation and heterogeneity: A 2024 Nature Communications study demonstrates that ASCL1 and OLIG2 are redundantly required for GBM initiation in a mouse model; they bind each other‚Äôs loci and share extensive genomic targets in GBM. ChIP analysis shows OLIG2 overlaps with over 90% of 13,457 ASCL1 peaks, and ~98% of ASCL1 target genes are also OLIG2 targets; motif analysis identifies enriched E-boxes with GC cores. Single-cell RNA-seq reveals high ASCL1 level specifies migratory NSC/astrocyte-like tumor states, while OLIG2 is necessary for efficient activation of oligodendrocyte lineage programs. URL: https://doi.org/10.1038/s41467-024-54750-9 (published Nov 2024). (myers2024transcriptionfactorsascl1 pages 1-2, myers2024transcriptionfactorsascl1 pages 14-15)<br />
- Lineage and receptor signaling plasticity around OLIG2: Contemporary summaries emphasize OLIG2‚Äôs role in reciprocal shifts between PDGFRA and EGFR signaling axes and its control over replication competence in glioma stem-like cells, consolidating a picture of OLIG2 as a linchpin for proneural/OPC-like programs. URL: https://doi.org/10.3389/fnins.2023.1129434 (May 2023). (szu2023biologicalfunctionsof pages 7-8, szu2023biologicalfunctionsof pages 4-5)<br />
- Spatial niche and chromatin context (forward-looking): Spatial epigenomic analyses propose small, localized OPC-like niches with OLIG2/OPC programs embedded within larger mesenchymal-like niches, with short- and long-range signaling shaping cell-state equilibria (preprint 2025 for context). URL: https://doi.org/10.1101/2025.05.09.653178 (posted May 14, 2025). While insightful for OLIG2-associated OPC-like states, this is preprint-stage beyond 2024. (kint2025spatialepigenomicniches pages 20-22)</p>
<p>3) Current applications and real-world implementations<br />
- Diagnostic utility (IHC): OLIG2 is a routine IHC marker in neuropathology to identify oligodendroglial lineage and diffuse gliomas, typically with strong nuclear staining; it is incorporated into diagnostic panels to distinguish glial tumors and assess lineage composition. Earlier pathology series and reviews consistently report high specificity and broad coverage across diffuse gliomas. (Frontiers in Neuroscience; May 2023; https://doi.org/10.3389/fnins.2023.1129434) (szu2023biologicalfunctionsof pages 3-4, szu2023biologicalfunctionsof pages 8-8)<br />
- Research and translational targeting: Small-molecule strategies that disrupt OLIG2 dimerization/activity (e.g., reported CT-179) have shown reductions in OLIG2+ tumor cells and survival benefits in preclinical models. Given OLIG2‚Äôs integration with Shh/EGFR/Notch networks and its repression of p53 acetylation/p21, pathway-combination strategies are under consideration in preclinical research. (Frontiers in Neuroscience; May 2023; https://doi.org/10.3389/fnins.2023.1129434) (szu2023biologicalfunctionsof pages 4-5)</p>
<p>4) Expert opinions and analysis from authoritative sources<br />
- Consensus from a 2023 peer-reviewed review: OLIG2 is a central lineage TF coupling neuron‚Äìglia fate choice and driving oligodendrogenesis; in cancer, OLIG2 sustains proliferation, opposes p53-mediated damage responses, and is broadly expressed in diffuse gliomas, nominating OLIG2 as both a diagnostic marker and therapeutic target. (Frontiers in Neuroscience; May 2023; https://doi.org/10.3389/fnins.2023.1129434) (szu2023biologicalfunctionsof pages 7-8, szu2023biologicalfunctionsof pages 4-5, szu2023biologicalfunctionsof pages 8-8)<br />
- 2024 primary mechanistic evidence: The ASCL1‚ÄìOLIG2 axis is now quantitatively mapped genome-wide in GBM, providing compelling evidence that OLIG2 is required for oligodendrocyte-lineage gene activation and that co-regulation with ASCL1 controls state composition, invasive properties, and initiation. These data refine models of OLIG2‚Äôs role beyond development into tumor ecology and therapeutic vulnerabilities. (Nature Communications; Nov 2024; https://doi.org/10.1038/s41467-024-54750-9) (myers2024transcriptionfactorsascl1 pages 1-2, myers2024transcriptionfactorsascl1 pages 14-15)</p>
<p>5) Relevant statistics and data (recent)<br />
- Genomic co-occupancy and target sharing (GBM): OLIG2 overlaps with &gt;90% of ASCL1 ChIP peaks (of 13,457 peaks) and ~98% of ASCL1 target genes are also OLIG2 targets; among 1,580 TCGA-correlated genes, 841 are direct shared targets (with ~40% nuclear-function and ~7% cell-cycle gene enrichments). Publication: Nov 2024; URL: https://doi.org/10.1038/s41467-024-54750-9. (myers2024transcriptionfactorsascl1 pages 1-2)<br />
- Immunophenotyping and lineage composition: Single-cell and IHC observations situate OLIG2 as a principal marker of OPC-like/proneural programs; examples in 2024 experiments report shifts in SOX10+ and OLIG2+ fractions depending on ASCL1/OLIG2 perturbation, consistent with OLIG2‚Äôs necessity for efficient activation of oligodendrocyte-lineage genes. Publication: Nov 2024; URL: https://doi.org/10.1038/s41467-024-54750-9. (myers2024transcriptionfactorsascl1 pages 14-15)<br />
- Developmental and cancer pathway linkages: Quantitative associations between Shh pathway activity and OLIG2 expression, and functional links to EGFR/Notch signaling, are consolidated in 2023 review summaries and primary references therein. Publication: May 2023; URL: https://doi.org/10.3389/fnins.2023.1129434. (szu2023biologicalfunctionsof pages 3-4, szu2023biologicalfunctionsof pages 4-5)</p>
<p>Functional annotation synthesis<br />
- Primary function: OLIG2 is a nuclear bHLH transcription factor that binds E-box motifs to specify and maintain oligodendrocyte lineage programs, promote OPC specification and differentiation, and regulate replication competence and stress responses by repressing p21 and antagonizing p53 acetylation. Function is modulated by phosphorylation and upstream Shh/Notch/EGFR pathways, and is enacted in cooperation with TFs such as ASCL1, SOX10, and NKX2.2. (Frontiers in Neuroscience; May 2023; https://doi.org/10.3389/fnins.2023.1129434; Nature Communications; Nov 2024; https://doi.org/10.1038/s41467-024-54750-9) (szu2023biologicalfunctionsof pages 4-5, szu2023biologicalfunctionsof pages 7-8, myers2024transcriptionfactorsascl1 pages 1-2)<br />
- Cellular context and localization: OLIG2 acts in the nucleus of OPCs and oligodendrocytes, as well as in OLIG2-positive tumor cells within gliomas. (Frontiers in Neuroscience; May 2023; https://doi.org/10.3389/fnins.2023.1129434) (szu2023biologicalfunctionsof pages 3-4)<br />
- Pathway placement and disease relevance: In development, Shh and cooperating pathways induce OLIG2 to drive ventral forebrain/spinal OPC programs; in gliomas, OLIG2 anchors OPC-like/proneural states and contributes to growth, therapy resistance, and cell-state plasticity. The 2024 ASCL1‚ÄìOLIG2 co-binding map provides a mechanistic bridge from lineage biology to glioma initiation and heterogeneity. (Frontiers in Neuroscience; May 2023; https://doi.org/10.3389/fnins.2023.1129434; Nature Communications; Nov 2024; https://doi.org/10.1038/s41467-024-54750-9) (szu2023biologicalfunctionsof pages 7-8, myers2024transcriptionfactorsascl1 pages 1-2, myers2024transcriptionfactorsascl1 pages 14-15)</p>
<p>Notes on verification and ambiguity<br />
- The gene symbol OLIG2 in the cited literature consistently refers to the human CNS bHLH transcription factor with oligodendroglial-lineage roles, matching UniProt Q13516. Core domain architecture (bHLH) and functional annotations align with UniProt, and no conflicting gene identifications were encountered in recent sources. (Frontiers in Neuroscience; May 2023; https://doi.org/10.3389/fnins.2023.1129434) (szu2023biologicalfunctionsof pages 7-8)</p>
<p>References (URLs and dates)<br />
- Szu JI, Tsigelny IF, Wojcinski A, Kesari S. Biological functions of the Olig gene family in brain cancer and therapeutic targeting. Frontiers in Neuroscience. 2023-05. URL: https://doi.org/10.3389/fnins.2023.1129434 (szu2023biologicalfunctionsof pages 8-9, szu2023biologicalfunctionsof pages 3-4, szu2023biologicalfunctionsof pages 4-5, szu2023biologicalfunctionsof pages 7-8, szu2023biologicalfunctionsof pages 8-8)<br />
- Myers BL, Brayer KJ, Paez-Beltran LE, et al. Transcription factors ASCL1 and OLIG2 drive glioblastoma initiation and co-regulate tumor cell types and migration. Nature Communications. 2024-11. URL: https://doi.org/10.1038/s41467-024-54750-9 (myers2024transcriptionfactorsascl1 pages 1-2, myers2024transcriptionfactorsascl1 pages 14-15)<br />
- Contextual/preprint beyond 2024: Kint S, Younes ST, Bao S, et al. Spatial epigenomic niches underlie glioblastoma cell state plasticity. bioRxiv. 2025-05-14. URL: https://doi.org/10.1101/2025.05.09.653178 (kint2025spatialepigenomicniches pages 20-22)<br />
- Additional context compilation (OLIG2 in lineage fate and gliomagenesis): Tian Y, et al. Orchestrating the acquisition of OPC vs interneuron fates through Olig1/2 during mammalian cortical gliogenesis and gliomagenesis. bioRxiv. 2024-11. URL: https://doi.org/10.1101/2024.11.11.623106 (tian2024orchestratingtheacquisition pages 32-37)</p>
<p>References</p>
<ol>
<li>
<p>(szu2023biologicalfunctionsof pages 8-9): Jenny I. Szu, Igor F. Tsigelny, Alexander Wojcinski, and Santosh Kesari. Biological functions of the olig gene family in brain cancer and therapeutic targeting. Frontiers in Neuroscience, May 2023. URL: https://doi.org/10.3389/fnins.2023.1129434, doi:10.3389/fnins.2023.1129434. This article has 18 citations and is from a peer-reviewed journal.</p>
</li>
<li>
<p>(szu2023biologicalfunctionsof pages 7-8): Jenny I. Szu, Igor F. Tsigelny, Alexander Wojcinski, and Santosh Kesari. Biological functions of the olig gene family in brain cancer and therapeutic targeting. Frontiers in Neuroscience, May 2023. URL: https://doi.org/10.3389/fnins.2023.1129434, doi:10.3389/fnins.2023.1129434. This article has 18 citations and is from a peer-reviewed journal.</p>
</li>
<li>
<p>(szu2023biologicalfunctionsof pages 3-4): Jenny I. Szu, Igor F. Tsigelny, Alexander Wojcinski, and Santosh Kesari. Biological functions of the olig gene family in brain cancer and therapeutic targeting. Frontiers in Neuroscience, May 2023. URL: https://doi.org/10.3389/fnins.2023.1129434, doi:10.3389/fnins.2023.1129434. This article has 18 citations and is from a peer-reviewed journal.</p>
</li>
<li>
<p>(szu2023biologicalfunctionsof pages 8-8): Jenny I. Szu, Igor F. Tsigelny, Alexander Wojcinski, and Santosh Kesari. Biological functions of the olig gene family in brain cancer and therapeutic targeting. Frontiers in Neuroscience, May 2023. URL: https://doi.org/10.3389/fnins.2023.1129434, doi:10.3389/fnins.2023.1129434. This article has 18 citations and is from a peer-reviewed journal.</p>
</li>
<li>
<p>(szu2023biologicalfunctionsof pages 4-5): Jenny I. Szu, Igor F. Tsigelny, Alexander Wojcinski, and Santosh Kesari. Biological functions of the olig gene family in brain cancer and therapeutic targeting. Frontiers in Neuroscience, May 2023. URL: https://doi.org/10.3389/fnins.2023.1129434, doi:10.3389/fnins.2023.1129434. This article has 18 citations and is from a peer-reviewed journal.</p>
</li>
<li>
<p>(myers2024transcriptionfactorsascl1 pages 1-2): Bianca L. Myers, Kathryn J. Brayer, Luis E. Paez-Beltran, Estrella Villicana, Matthew S. Keith, Hideaki Suzuki, Jessie Newville, Rebekka H. Anderson, Yunee Lo, Conner M. Mertz, Rahul K. Kollipara, Mark D. Borromeo, Q. Richard Lu, Robert M. Bachoo, Jane E. Johnson, and Tou Yia Vue. Transcription factors ascl1 and olig2 drive glioblastoma initiation and co-regulate tumor cell types and migration. Nature Communications, Nov 2024. URL: https://doi.org/10.1038/s41467-024-54750-9, doi:10.1038/s41467-024-54750-9. This article has 28 citations and is from a highest quality peer-reviewed journal.</p>
</li>
<li>
<p>(myers2024transcriptionfactorsascl1 pages 14-15): Bianca L. Myers, Kathryn J. Brayer, Luis E. Paez-Beltran, Estrella Villicana, Matthew S. Keith, Hideaki Suzuki, Jessie Newville, Rebekka H. Anderson, Yunee Lo, Conner M. Mertz, Rahul K. Kollipara, Mark D. Borromeo, Q. Richard Lu, Robert M. Bachoo, Jane E. Johnson, and Tou Yia Vue. Transcription factors ascl1 and olig2 drive glioblastoma initiation and co-regulate tumor cell types and migration. Nature Communications, Nov 2024. URL: https://doi.org/10.1038/s41467-024-54750-9, doi:10.1038/s41467-024-54750-9. This article has 28 citations and is from a highest quality peer-reviewed journal.</p>
</li>
<li>
<p>(kint2025spatialepigenomicniches pages 20-22): Sam Kint, Subhi Talal Younes, Shuozhen Bao, Gretchen Long, David Wouters, Erin Stephenson, Xing Lou, Mei Zhong, Di Zhang, Graham Su, Archibald Enninful, Mingyu Yang, Huey-Miin Chen, Katrina Ellestad, Colleen Anderson, Jennifer Moliterno, John Kelly, Jennifer A Chan, Alejandro Sifrim, Jiangbing Zhou, Ana Nikolic, Rong Fan, and Marco Gallo. Spatial epigenomic niches underlie glioblastoma cell state plasticity. bioRxiv, May 2025. URL: https://doi.org/10.1101/2025.05.09.653178, doi:10.1101/2025.05.09.653178. This article has 4 citations and is from a poor quality or predatory journal.</p>
</li>
<li>
<p>(tian2024orchestratingtheacquisition pages 32-37): Yu Tian, Ziwu Wang, Feihong Yang, Wen Zhang, Jialin Li, Lin Yang, Tongye Fu, Wenhui Zheng, Zhejun Xu, Tong Ma, Yan You, Xiaosu Li, Jiangang Song, Yunli Xie, Zhengang Yang, and Zhuangzhi Zhang. Orchestrating the acquisition of oligodendrocyte precursor cell versus olfactory bulb interneuron fates through olig1/2 during mammalian cortical gliogenesis and gliomagenesis. bioRxiv, Nov 2024. URL: https://doi.org/10.1101/2024.11.11.623106, doi:10.1101/2024.11.11.623106. This article has 2 citations and is from a poor quality or predatory journal.</p>
</li>
</ol>
<h2 id="citations">Citations</h2>
<ol>
<li>szu2023biologicalfunctionsof pages 7-8</li>
<li>szu2023biologicalfunctionsof pages 4-5</li>
<li>kint2025spatialepigenomicniches pages 20-22</li>
<li>szu2023biologicalfunctionsof pages 3-4</li>
<li>tian2024orchestratingtheacquisition pages 32-37</li>
<li>szu2023biologicalfunctionsof pages 8-9</li>
<li>szu2023biologicalfunctionsof pages 8-8</li>
<li>https://doi.org/10.3389/fnins.2023.1129434</li>
<li>https://doi.org/10.1038/s41467-024-54750-9</li>
<li>https://doi.org/10.1101/2025.05.09.653178</li>
<li>https://doi.org/10.1038/s41467-024-54750-9.</li>
<li>https://doi.org/10.3389/fnins.2023.1129434.</li>
<li>https://doi.org/10.3389/fnins.2023.1129434;</li>
<li>https://doi.org/10.1101/2024.11.11.623106</li>
<li>https://doi.org/10.3389/fnins.2023.1129434,</li>
<li>https://doi.org/10.1038/s41467-024-54750-9,</li>
<li>https://doi.org/10.1101/2025.05.09.653178,</li>
<li>https://doi.org/10.1101/2024.11.11.623106,</li>
</ol>
            </div>
        </details>
        
    </div>
    

    <!-- YAML Preview Section -->
    <div class="section">
        <details class="yaml-preview">
            <summary>
                <h2 style="display: inline;">üìÑ View Raw YAML</h2>
            </summary>
            <div class="yaml-content">
                <pre><code>id: Q13516
gene_symbol: OLIG2
product_type: PROTEIN
status: COMPLETE
taxon:
  id: NCBITaxon:9606
  label: Homo sapiens
description: &gt;-
  OLIG2 (Oligodendrocyte transcription factor 2) is a Class B/E basic helix-loop-helix (bHLH)
  transcription factor that functions as a master regulator of oligodendrocyte and motor neuron
  lineage specification in the central nervous system. OLIG2 binds E-box DNA motifs (CANNTG)
  as homo- or heterodimers with other bHLH proteins, regulating transcription of genes essential
  for neural cell fate determination. The protein is induced by Sonic hedgehog (Shh) signaling
  and cooperates with transcription factors NKX2-2, OLIG1, SOX10, and ASCL1 to establish the
  pMN (motor neuron progenitor) domain of the ventral neural tube, promoting oligodendrocyte
  precursor cell (OPC) specification and oligodendrocyte differentiation while antagonizing
  V2/V3 interneuron fates. OLIG2 also functions in cell cycle regulation by repressing p21
  and antagonizing p53 acetylation. The protein localizes primarily to the nucleus where it
  associates with chromatin, though cytoplasmic localization can occur when the nuclear
  localization signal in the bHLH domain is masked. OLIG2 is a diagnostic marker for diffuse
  gliomas, where it maintains OPC-like/proneural tumor states.
existing_annotations:
- term:
    id: GO:0000981
    label: DNA-binding transcription factor activity, RNA polymerase II-specific
  evidence_type: IBA
  original_reference_id: GO_REF:0000033
  review:
    summary: &gt;-
      OLIG2 is a well-established bHLH transcription factor that regulates gene
      expression during neural development. UniProt confirms OLIG2 is &#34;required for
      oligodendrocyte and motor neuron specification&#34; and functions as a transcriptional
      regulator. The bHLH domain (residues 108-162) is essential for DNA binding.
      This is a core function of OLIG2.
    action: ACCEPT
    reason: &gt;-
      OLIG2 is definitively a DNA-binding transcription factor. The bHLH domain
      is well-characterized and the protein functions to regulate transcription
      of genes involved in oligodendrocyte and motor neuron specification. This
      IBA annotation accurately reflects the core molecular function.
    supported_by:
      - reference_id: UniProtKB:Q13516
        supporting_text: &#34;Required for oligodendrocyte and motor neuron specification in the spinal cord&#34;
      - reference_id: UniProtKB:Q13516
        supporting_text: &#34;Class B basic helix-loop-helix protein 1&#34;

- term:
    id: GO:0005634
    label: nucleus
  evidence_type: IBA
  original_reference_id: GO_REF:0000033
  review:
    summary: &gt;-
      OLIG2 is primarily a nuclear protein as expected for a transcription factor.
      UniProt indicates nucleus as the primary subcellular location with evidence
      from PROSITE-ProRule:PRU00981.
    action: ACCEPT
    reason: &gt;-
      As a transcription factor, OLIG2 must localize to the nucleus to perform
      its function. UniProt confirms nuclear localization. The bHLH domain
      contains a nuclear localization signal that may be masked in the native
      form until interaction with partner proteins.
    supported_by:
      - reference_id: UniProtKB:Q13516
        supporting_text: &#34;SUBCELLULAR LOCATION: Nucleus&#34;
      - reference_id: UniProtKB:Q13516
        supporting_text: &#34;The NLS contained in the bHLH domain could be masked in the native form&#34;

- term:
    id: GO:0007423
    label: sensory organ development
  evidence_type: IBA
  original_reference_id: GO_REF:0000033
  review:
    summary: &gt;-
      OLIG2 is specifically involved in oligodendrocyte and motor neuron specification
      in the CNS (brain and spinal cord). There is no evidence that OLIG2 functions
      in sensory organ (eye, ear, nose) development. This IBA annotation appears
      to be an over-propagation from other bHLH family members that do function
      in sensory organs.
    action: REMOVE
    reason: &gt;-
      OLIG2&#39;s documented functions are restricted to oligodendrocyte differentiation
      and motor neuron specification in the neural tube and CNS. UniProt describes
      its function as &#34;Required for oligodendrocyte and motor neuron specification
      in the spinal cord, as well as for the development of somatic motor neurons
      in the hindbrain.&#34; There is no mention of sensory organ development. The
      IBA propagation from other bHLH family members is inappropriate here as
      OLIG2 has specialized neural tube functions distinct from sensory organ
      development. This is likely phylogenetic over-propagation from other family
      members like ATOH1 or NEUROD1 which do function in sensory development.
    supported_by:
      - reference_id: UniProtKB:Q13516
        supporting_text: &#34;Required for oligodendrocyte and motor neuron specification in the spinal cord, as well as for the development of somatic motor neurons in the hindbrain&#34;

- term:
    id: GO:0070888
    label: E-box binding
  evidence_type: IBA
  original_reference_id: GO_REF:0000033
  review:
    summary: &gt;-
      bHLH transcription factors characteristically bind E-box sequences (CANNTG).
      OLIG2 contains a canonical bHLH domain and is expected to bind E-box motifs.
      The SELEX study (PMID:28473536) systematically analyzed DNA binding of human
      transcription factors including bHLH proteins.
    action: ACCEPT
    reason: &gt;-
      E-box binding is the canonical DNA binding specificity for bHLH transcription
      factors. OLIG2&#39;s bHLH domain (residues 108-162) is well-conserved and the
      protein belongs to the class B bHLH family. This is a core molecular function.
    supported_by:
      - reference_id: UniProtKB:Q13516
        supporting_text: &#34;Class B basic helix-loop-helix protein 1&#34;
      - reference_id: PMID:28473536
        supporting_text: &#34;systematic analysis of DNA binding specificities of full-length TFs&#34;

- term:
    id: GO:0045944
    label: positive regulation of transcription by RNA polymerase II
  evidence_type: IBA
  original_reference_id: GO_REF:0000033
  review:
    summary: &gt;-
      OLIG2 functions as a transcription factor that promotes oligodendrocyte and
      motor neuron gene expression programs. It cooperates with other factors like
      ZNF488 to activate transcription of oligodendrocyte differentiation genes.
    action: ACCEPT
    reason: &gt;-
      OLIG2 is documented to promote oligodendrocyte differentiation by activating
      target genes. UniProt states it &#34;Functions together with ZNF488 to promote
      oligodendrocyte differentiation.&#34; This positive transcriptional regulation
      is a core function.
    supported_by:
      - reference_id: UniProtKB:Q13516
        supporting_text: &#34;Functions together with ZNF488 to promote oligodendrocyte differentiation&#34;

- term:
    id: GO:0061564
    label: axon development
  evidence_type: IBA
  original_reference_id: GO_REF:0000033
  review:
    summary: &gt;-
      OLIG2&#39;s primary functions are in oligodendrocyte and motor neuron cell fate
      specification. While oligodendrocytes myelinate axons, OLIG2 itself does not
      directly regulate axon development processes. Motor neurons do extend axons,
      but OLIG2&#39;s role is in specifying motor neuron identity, not in axon growth
      or guidance per se.
    action: KEEP_AS_NON_CORE
    reason: &gt;-
      Axon development is an indirect downstream consequence of OLIG2&#39;s role in
      motor neuron specification. OLIG2 specifies motor neuron identity; the
      resulting motor neurons then extend axons. However, OLIG2 is not known to
      directly regulate axon development genes or processes. This is a secondary
      effect rather than a core function. The annotation is not wrong but
      represents a downstream phenotypic effect.
    supported_by:
      - reference_id: UniProtKB:Q13516
        supporting_text: &#34;Required for oligodendrocyte and motor neuron specification in the spinal cord&#34;

- term:
    id: GO:0003677
    label: DNA binding
  evidence_type: IEA
  original_reference_id: GO_REF:0000043
  review:
    summary: &gt;-
      OLIG2 contains a bHLH domain that mediates DNA binding. This is a more
      general term than the more specific annotations for E-box binding and
      transcription factor activity.
    action: ACCEPT
    reason: &gt;-
      This is a valid general annotation. OLIG2&#39;s bHLH domain binds DNA. While
      more specific terms like E-box binding (GO:0070888) are also present,
      keeping this general annotation provides appropriate coverage. The IEA
      from UniProt keyword mapping is appropriate.
    supported_by:
      - reference_id: UniProtKB:Q13516
        supporting_text: &#34;Class B basic helix-loop-helix protein 1&#34;

- term:
    id: GO:0003700
    label: DNA-binding transcription factor activity
  evidence_type: IEA
  original_reference_id: GO_REF:0000120
  review:
    summary: &gt;-
      This is the parent term of GO:0000981 (RNA polymerase II-specific). OLIG2
      is clearly a DNA-binding transcription factor.
    action: ACCEPT
    reason: &gt;-
      Valid but more general than GO:0000981 which is also annotated. Both
      annotations are acceptable - the IEA provides a broader term while the
      IBA provides the more specific Pol II-specific term.
    supported_by:
      - reference_id: UniProtKB:Q13516
        supporting_text: &#34;Required for oligodendrocyte and motor neuron specification&#34;

- term:
    id: GO:0005634
    label: nucleus
  evidence_type: IEA
  original_reference_id: GO_REF:0000120
  review:
    summary: &gt;-
      Duplicate of the IBA annotation for nucleus. OLIG2 localizes to the nucleus
      as expected for a transcription factor.
    action: ACCEPT
    reason: &gt;-
      Correct annotation. Having both IBA and IEA evidence for nuclear localization
      is fine - they represent independent evidence sources confirming the same
      localization.
    supported_by:
      - reference_id: UniProtKB:Q13516
        supporting_text: &#34;SUBCELLULAR LOCATION: Nucleus&#34;

- term:
    id: GO:0005737
    label: cytoplasm
  evidence_type: IEA
  original_reference_id: GO_REF:0000120
  review:
    summary: &gt;-
      UniProt indicates OLIG2 is also found in the cytoplasm. The nuclear
      localization signal in the bHLH domain may be masked, allowing cytoplasmic
      localization until partner protein interaction triggers nuclear import.
    action: ACCEPT
    reason: &gt;-
      UniProt explicitly states cytoplasmic localization by similarity evidence.
      The annotation notes that the NLS may be masked in the native form,
      explaining dual nuclear/cytoplasmic distribution.
    supported_by:
      - reference_id: UniProtKB:Q13516
        supporting_text: &#34;Cytoplasm {ECO:0000250}&#34;
      - reference_id: UniProtKB:Q13516
        supporting_text: &#34;The NLS contained in the bHLH domain could be masked in the native form and translocation to the nucleus could be mediated by interaction either with class E bHLH partner protein or with NKX2-2&#34;

- term:
    id: GO:0006355
    label: regulation of DNA-templated transcription
  evidence_type: IEA
  original_reference_id: GO_REF:0000002
  review:
    summary: &gt;-
      OLIG2 is a transcription factor that regulates gene expression. This
      general biological process term accurately describes its function.
    action: ACCEPT
    reason: &gt;-
      Correct general term for OLIG2&#39;s role as a transcriptional regulator.
      While more specific terms for positive regulation are also present,
      this broader term appropriately captures the general function.
    supported_by:
      - reference_id: UniProtKB:Q13516
        supporting_text: &#34;Transcription; Transcription regulation&#34;

- term:
    id: GO:0021778
    label: oligodendrocyte cell fate specification
  evidence_type: IEA
  original_reference_id: GO_REF:0000002
  review:
    summary: &gt;-
      OLIG2 is essential for oligodendrocyte cell fate specification. This is a core function.
      Note on specification vs commitment distinction: &#34;Specification&#34; is the appropriate term
      because early OLIG2+ cells in the pMN domain can give rise to EITHER motor neurons OR
      oligodendrocytes depending on developmental timing and signals - the fate is reversible
      and context-dependent, which is the definition of specification per Slack (2011).
    action: ACCEPT
    reason: &gt;-
      This is a core function of OLIG2. UniProt explicitly states OLIG2 is &#34;Required for
      oligodendrocyte and motor neuron specification.&#34; The protein establishes the pMN domain
      which gives rise to both motor neurons (early) and oligodendrocytes (later). The term
      &#34;specification&#34; (not &#34;commitment&#34;) is appropriate because OLIG2+ cells retain plasticity
      to become either cell type depending on developmental context.
    supported_by:
      - reference_id: UniProtKB:Q13516
        supporting_text: &#34;Required for oligodendrocyte and motor neuron specification in the spinal cord&#34;
      - reference_id: file:human/OLIG2/OLIG2-deep-research-falcon.md
        supporting_text: &#34;OLIG2 orchestrates neuron-glia fate decisions and is required for OPC specification and oligodendrocyte differentiation&#34;

- term:
    id: GO:0021779
    label: oligodendrocyte cell fate commitment
  evidence_type: TAS
  original_reference_id: file:human/OLIG2/OLIG2-deep-research-falcon.md
  review:
    summary: &gt;-
      OLIG2 is also involved in oligodendrocyte cell fate commitment, which occurs after
      specification when OPCs become irreversibly restricted to the oligodendrocyte lineage.
      OLIG2 remains expressed in OPCs and is required for maintaining oligodendrocyte lineage
      identity.
    action: NEW
    reason: &gt;-
      While GO:0021778 (specification) captures OLIG2&#39;s early role in the pMN domain where
      fate is still plastic, OLIG2 also functions in the later commitment stage. Once cells
      progress to the OPC stage, OLIG2 (together with factors like SOX10 and NKX2.2) maintains
      commitment to the oligodendrocyte lineage. This annotation complements the specification
      term by capturing OLIG2&#39;s continued role throughout oligodendrogenesis.
    supported_by:
      - reference_id: UniProtKB:Q13516
        supporting_text: &#34;Required for oligodendrocyte and motor neuron specification in the spinal cord&#34;
      - reference_id: file:human/OLIG2/OLIG2-deep-research-falcon.md
        supporting_text: &#34;OLIG2 is required for OPC specification and oligodendrocyte differentiation&#34;

- term:
    id: GO:0030182
    label: neuron differentiation
  evidence_type: IEA
  original_reference_id: GO_REF:0000002
  review:
    summary: &gt;-
      OLIG2 promotes motor neuron differentiation in the spinal cord and hindbrain.
      This general term is appropriate but more specific terms exist.
    action: MODIFY
    reason: &gt;-
      While technically correct, OLIG2 specifically promotes motor neuron
      differentiation, not general neuron differentiation. In fact, OLIG2
      antagonizes V2 and V3 interneuron fates. A more specific term would
      better capture OLIG2&#39;s function.
    proposed_replacement_terms:
      - id: GO:0021522
        label: spinal cord motor neuron differentiation
    supported_by:
      - reference_id: UniProtKB:Q13516
        supporting_text: &#34;Required for oligodendrocyte and motor neuron specification in the spinal cord, as well as for the development of somatic motor neurons in the hindbrain&#34;
      - reference_id: UniProtKB:Q13516
        supporting_text: &#34;Antagonist of V2 interneuron and of NKX2-2-induced V3 interneuron development&#34;

- term:
    id: GO:0042552
    label: myelination
  evidence_type: IEA
  original_reference_id: GO_REF:0000002
  review:
    summary: &gt;-
      OLIG2 promotes oligodendrocyte differentiation, and oligodendrocytes are
      responsible for myelination in the CNS. However, OLIG2 itself does not
      directly participate in the myelination process.
    action: KEEP_AS_NON_CORE
    reason: &gt;-
      Myelination is an indirect downstream effect of OLIG2&#39;s role in
      oligodendrocyte specification. OLIG2 specifies oligodendrocyte fate;
      the resulting oligodendrocytes then myelinate axons. OLIG2 is not
      expressed in mature myelinating oligodendrocytes and does not directly
      regulate myelin genes. This is a secondary phenotypic consequence
      rather than a direct function.
    supported_by:
      - reference_id: UniProtKB:Q13516
        supporting_text: &#34;Required for oligodendrocyte and motor neuron specification&#34;

- term:
    id: GO:0046983
    label: protein dimerization activity
  evidence_type: IEA
  original_reference_id: GO_REF:0000002
  review:
    summary: &gt;-
      bHLH transcription factors function as dimers. OLIG2&#39;s bHLH domain
      mediates homo- and heterodimerization with other bHLH proteins.
    action: ACCEPT
    reason: &gt;-
      Protein dimerization is essential for bHLH transcription factor function.
      OLIG2 interacts with NKX2-2 and ZNF488 through its bHLH domain. This
      is a core molecular function required for DNA binding and transcriptional
      activity.
    supported_by:
      - reference_id: UniProtKB:Q13516
        supporting_text: &#34;The bHLH is essential for interaction with NKX2-2&#34;
      - reference_id: UniProtKB:Q13516
        supporting_text: &#34;Interacts with NKX2-2. Interacts with ZNF488&#34;

- term:
    id: GO:0048709
    label: oligodendrocyte differentiation
  evidence_type: IEA
  original_reference_id: GO_REF:0000002
  review:
    summary: &gt;-
      OLIG2 is required for oligodendrocyte differentiation. This is a core
      biological process function of the protein.
    action: ACCEPT
    reason: &gt;-
      Oligodendrocyte differentiation is one of the primary functions of OLIG2.
      UniProt states it &#34;Functions together with ZNF488 to promote oligodendrocyte
      differentiation.&#34; This IEA annotation accurately captures a core function.
    supported_by:
      - reference_id: UniProtKB:Q13516
        supporting_text: &#34;Functions together with ZNF488 to promote oligodendrocyte differentiation&#34;

- term:
    id: GO:1990837
    label: sequence-specific double-stranded DNA binding
  evidence_type: IEA
  original_reference_id: GO_REF:0000117
  review:
    summary: &gt;-
      OLIG2 binds specific DNA sequences (E-boxes) through its bHLH domain.
      This annotation from ARBA machine learning is appropriate.
    action: ACCEPT
    reason: &gt;-
      OLIG2&#39;s bHLH domain binds E-box sequences specifically. This is a valid
      molecular function annotation that is also supported by IDA evidence
      (PMID:28473536).
    supported_by:
      - reference_id: UniProtKB:Q13516
        supporting_text: &#34;Class B basic helix-loop-helix protein 1&#34;

- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:32296183
  review:
    summary: &gt;-
      The HuRI study (PMID:32296183) identified protein-protein interactions
      for OLIG2 using yeast two-hybrid screens. However, GO:0005515 &#34;protein
      binding&#34; is an uninformative term that should be avoided.
    action: REMOVE
    reason: &gt;-
      &#34;Protein binding&#34; (GO:0005515) is too general to be informative. The
      HuRI paper is a large-scale interactome study that does not characterize
      specific functional interactions of OLIG2. Per curation guidelines,
      this term should be replaced with more specific binding terms. OLIG2&#39;s
      known specific interactions (with NKX2-2, ZNF488, class E bHLH proteins)
      are functionally relevant but this generic annotation does not capture
      them appropriately.
    supported_by:
      - reference_id: PMID:32296183
        supporting_text: &#34;we present a human &#39;all-by-all&#39; reference interactome map of human binary protein interactions, or &#39;HuRI&#39;&#34;

- term:
    id: GO:0000981
    label: DNA-binding transcription factor activity, RNA polymerase II-specific
  evidence_type: IEA
  original_reference_id: GO_REF:0000107
  review:
    summary: &gt;-
      Duplicate of the IBA annotation. OLIG2 is an RNA Pol II-specific
      transcription factor.
    action: ACCEPT
    reason: &gt;-
      This IEA from Ensembl Compara ortholog transfer is consistent with the
      IBA annotation. Having multiple evidence types supporting the same
      annotation increases confidence.
    supported_by:
      - reference_id: UniProtKB:Q13516
        supporting_text: &#34;Transcription; Transcription regulation&#34;

- term:
    id: GO:0042802
    label: identical protein binding
  evidence_type: IEA
  original_reference_id: GO_REF:0000107
  review:
    summary: &gt;-
      bHLH proteins can form homodimers as well as heterodimers. OLIG2 likely
      homodimerizes through its bHLH domain.
    action: ACCEPT
    reason: &gt;-
      Homodimerization is a common property of bHLH transcription factors.
      While OLIG2&#39;s heterodimeric interactions are better characterized
      (with NKX2-2, ZNF488, class E bHLH partners), homodimerization is
      plausible and consistent with the protein family.
    supported_by:
      - reference_id: UniProtKB:Q13516
        supporting_text: &#34;Class B basic helix-loop-helix protein 1&#34;

- term:
    id: GO:0071837
    label: HMG box domain binding
  evidence_type: IEA
  original_reference_id: GO_REF:0000107
  review:
    summary: &gt;-
      OLIG2 interacts with NKX2-2, which contains a homeodomain. However,
      NKX2-2 does not contain an HMG box domain. This annotation may be
      an error in ortholog transfer.
    action: UNDECIDED
    reason: &gt;-
      The annotation source is Ensembl Compara ortholog transfer. NKX2-2,
      a known OLIG2 partner, has a homeodomain but not an HMG box. SOX
      proteins have HMG boxes and interact with bHLH factors in neural
      development, but specific OLIG2-HMG box protein interactions are
      not well documented. Unable to verify this annotation without
      additional evidence.
    supported_by:
      - reference_id: UniProtKB:Q13516
        supporting_text: &#34;Interacts with NKX2-2. Interacts with ZNF488&#34;

- term:
    id: GO:1990837
    label: sequence-specific double-stranded DNA binding
  evidence_type: IDA
  original_reference_id: PMID:28473536
  review:
    summary: &gt;-
      The Taipale lab SELEX study systematically characterized DNA binding
      specificities of human transcription factors. OLIG2 was among the
      542 TFs analyzed.
    action: ACCEPT
    reason: &gt;-
      This IDA annotation is based on direct experimental evidence from
      methylation-sensitive SELEX analysis. The study provides systematic
      characterization of transcription factor DNA binding specificities.
      This is a core molecular function of OLIG2.
    supported_by:
      - reference_id: PMID:28473536
        supporting_text: &#34;By analysis of 542 human TFs with methylation-sensitive SELEX (systematic evolution of ligands by exponential enrichment)&#34;

- term:
    id: GO:0000785
    label: chromatin
  evidence_type: ISA
  original_reference_id: GO_REF:0000113
  review:
    summary: &gt;-
      Transcription factors bind to chromatin to regulate gene expression.
      OLIG2 is expected to associate with chromatin as part of its function.
    action: ACCEPT
    reason: &gt;-
      As a DNA-binding transcription factor, OLIG2 functions on chromatin.
      The ISA annotation from TFClass database is appropriate for a sequence-
      specific transcription factor.
    supported_by:
      - reference_id: UniProtKB:Q13516
        supporting_text: &#34;Chromosomal rearrangement; Cytoplasm; Developmental protein; DNA-binding&#34;

- term:
    id: GO:0000981
    label: DNA-binding transcription factor activity, RNA polymerase II-specific
  evidence_type: ISA
  original_reference_id: GO_REF:0000113
  review:
    summary: &gt;-
      Third annotation for the same term from TFClass database. OLIG2 is
      classified as a sequence-specific DNA binding transcription factor.
    action: ACCEPT
    reason: &gt;-
      This ISA annotation from TFClass provides additional evidence for
      OLIG2&#39;s function as an RNA Pol II-specific transcription factor.
      Multiple evidence types converge on this core function.
    supported_by:
      - reference_id: UniProtKB:Q13516
        supporting_text: &#34;Transcription; Transcription regulation&#34;

- term:
    id: GO:0006338
    label: chromatin remodeling
  evidence_type: TAS
  original_reference_id: file:human/OLIG2/OLIG2-deep-research-cyberian.md
  review:
    summary: &gt;-
      OLIG2 functions as a chromatin pre-patterning factor that recruits the SWI/SNF
      chromatin remodeler BRG1/SMARCA4 to oligodendrocyte-specific enhancers before
      differentiation begins. This OLIG2-BRG1 axis is required for initiating
      oligodendrocyte lineage progression. OLIG2 also recruits SETDB1 for H3K9me3
      repressive modification.
    action: NEW
    reason: &gt;-
      This function is documented in Yu et al. 2013 (Cell) and represents a key
      mechanistic insight into how OLIG2 regulates oligodendrocyte differentiation
      at the chromatin level. The chromatin pre-patterning function is distinct from
      OLIG2&#39;s direct transcriptional regulation and is not currently annotated in GO.
    supported_by:
      - reference_id: file:human/OLIG2/OLIG2-deep-research-cyberian.md
        supporting_text: &#34;OLIG2 functions as a &#39;pre-patterning factor&#39; that directs BRG1 to oligodendrocyte-specific enhancers before differentiation begins&#34;
      - reference_id: file:human/OLIG2/OLIG2-deep-research-cyberian.md
        supporting_text: &#34;Approximately 71% of BRG1 binding regions contain E-box motifs recognized by OLIG2&#34;

references:
- id: GO_REF:0000002
  title: Gene Ontology annotation through association of InterPro records with GO terms
  findings:
    - statement: Provides IEA annotations based on InterPro domain content
- id: GO_REF:0000033
  title: Annotation inferences using phylogenetic trees
  findings:
    - statement: Source of IBA annotations propagated from characterized family members
- id: GO_REF:0000043
  title: Gene Ontology annotation based on UniProtKB/Swiss-Prot keyword mapping
  findings:
    - statement: Maps UniProt keywords to GO terms
- id: GO_REF:0000107
  title: Automatic transfer of experimentally verified manual GO annotation data to orthologs using Ensembl Compara
  findings:
    - statement: Transfers annotations from orthologs with experimental evidence
- id: GO_REF:0000113
  title: Gene Ontology annotation of human sequence-specific DNA binding transcription factors (DbTFs) based on the TFClass database
  findings:
    - statement: Provides ISA annotations for transcription factors classified in TFClass
- id: GO_REF:0000117
  title: Electronic Gene Ontology annotations created by ARBA machine learning models
  findings:
    - statement: Machine learning-based annotation predictions
- id: GO_REF:0000120
  title: Combined Automated Annotation using Multiple IEA Methods
  findings:
    - statement: Combines multiple IEA sources for consensus annotations
- id: PMID:28473536
  title: Impact of cytosine methylation on DNA binding specificities of human transcription factors.
  findings:
    - statement: Systematically characterized DNA binding specificities of 542 human TFs using SELEX
      supporting_text: &#34;By analysis of 542 human TFs with methylation-sensitive SELEX&#34;
    - statement: OLIG2 was among the transcription factors analyzed
      supporting_text: &#34;systematic analysis of DNA binding specificities of full-length TFs&#34;
- id: PMID:32296183
  title: A reference map of the human binary protein interactome.
  findings:
    - statement: Large-scale yeast two-hybrid interactome mapping (HuRI)
      supporting_text: &#34;we present a human &#39;all-by-all&#39; reference interactome map&#34;
    - statement: Identified protein-protein interactions for OLIG2
      supporting_text: &#34;HuRI has approximately four times as many such interactions&#34;
- id: file:human/OLIG2/OLIG2-deep-research-falcon.md
  title: Deep research synthesis on OLIG2 function
  findings:
    - statement: OLIG2 is a Class B/E basic helix-loop-helix transcription factor that binds E-box DNA motifs to regulate lineage programs
    - statement: OLIG2 orchestrates neuron-glia fate decisions and is required for OPC specification and oligodendrocyte differentiation
    - statement: OLIG2 represses p21 and antagonizes p53 acetylation to support replication competence
    - statement: Functional partners include ASCL1, SOX10, and NKX2.2 in the oligodendroglial gene regulatory network
    - statement: OLIG2 is induced by Sonic hedgehog (Shh) and participates in cross-talk with FGF and EGFR signaling

- id: file:human/OLIG2/OLIG2-deep-research-cyberian.md
  title: Comprehensive OLIG2 gene research with detailed citations
  findings:
    - statement: OLIG2 homodimers function as transcriptional repressors while heterodimers with E47 can activate transcription
      supporting_text: &#34;OLIG2 homodimers tend to function as transcriptional repressors, while heterodimers with E47 can activate transcription of target genes such as the Sox10 enhancer&#34;
    - statement: Phosphorylation of OLIG2 at Serine 147 regulates the motor neuron-to-oligodendrocyte fate switch
      supporting_text: &#34;Serine 147, located within the helix-loop-helix domain, is the key regulatory residue. When phosphorylated, OLIG2 preferentially forms homodimers...when S147 is dephosphorylated, OLIG2 shifts to preferentially forming heterodimers with NGN2&#34;
    - statement: OLIG2 interacts with chromatin remodeler BRG1/SMARCA4 to initiate oligodendrocyte differentiation
      supporting_text: &#34;OLIG2 functions as a &#39;pre-patterning factor&#39; that directs BRG1 to oligodendrocyte-specific enhancers before differentiation begins&#34;
    - statement: OLIG2 recruits SETDB1 for H3K9me3 repressive modification on genes like Sox11
      supporting_text: &#34;OLIG2 recruits the histone methyltransferase SETDB1 for H3K9me3 modification. This repressive epigenetic mechanism targets genes like Sox11&#34;
    - statement: Nuclear-to-cytoplasmic translocation of OLIG2 is essential for astrocyte differentiation
      supporting_text: &#34;The translocation of OLIG2 to the cytoplasm is promoted by activated AKT kinase through the PI3K signaling pathway&#34;

- id: PMID:11567617
  title: The bHLH transcription factor Olig2 promotes oligodendrocyte differentiation in collaboration with Nkx2.2
  findings:
    - statement: OLIG2 and NKX2.2 co-expression promotes oligodendrocyte differentiation through transcriptional repression
      supporting_text: &#34;Coexpression of Olig2 with Nkx2.2 in the spinal cord promotes ectopic and precocious oligodendrocyte differentiation. Both proteins function as transcriptional repressors in this assay.&#34;

- id: PMID:12121626
  title: The basic helix-loop-helix factor olig2 is essential for the development of motoneuron and oligodendrocyte lineages
  findings:
    - statement: OLIG2 knockout mice lose both motor neurons and oligodendrocytes, with cells converting to astrocyte fate
      supporting_text: &#34;motoneurons are largely eliminated and oligodendrocytes are not produced&#34;
    - statement: First evidence that a single gene controls specification of two neural cell types
      supporting_text: &#34;Our data provide the first evidence that a single gene mutation leads to the loss of two cell types, motoneuron and oligodendrocyte.&#34;

- id: PMID:21382552
  title: Phosphorylation regulates OLIG2 cofactor choice and the motor neuron-oligodendrocyte fate switch
  findings:
    - statement: S147 phosphorylation state determines motor neuron vs oligodendrocyte fate
      supporting_text: &#34;We found that Serine 147 in the helix-loop-helix domain of OLIG2 was phosphorylated during MN production and dephosphorylated at the onset of OLP genesis&#34;
    - statement: S147A mutation abolishes motor neuron production without preventing oligodendrocyte production
      supporting_text: &#34;Mutating Serine 147 to Alanine (S147A) abolished MN production without preventing OLP production in transgenic mice, chicks, or cultured P19 cells&#34;

core_functions:
  - description: &gt;-
      OLIG2 acts as a DNA-binding transcription factor that binds E-box motifs to activate
      transcription of oligodendrocyte lineage genes, driving oligodendrocyte precursor cell
      (OPC) specification and oligodendrocyte differentiation. This represents the primary
      core function of OLIG2 as a master regulator of oligodendrogenesis.
    molecular_function:
      id: GO:0000981
      label: DNA-binding transcription factor activity, RNA polymerase II-specific
    directly_involved_in:
      - id: GO:0021778
        label: oligodendrocyte cell fate specification
      - id: GO:0048709
        label: oligodendrocyte differentiation
      - id: GO:0045944
        label: positive regulation of transcription by RNA polymerase II
    locations:
      - id: GO:0005634
        label: nucleus
      - id: GO:0000785
        label: chromatin
    anatomical_locations:
      - id: UBERON:0002240
        label: spinal cord
      - id: UBERON:0000955
        label: brain

  - description: &gt;-
      OLIG2 functions as a transcriptional regulator to specify motor neuron fate in the
      pMN domain of the ventral neural tube. OLIG2 cooperates with NKX2-2 to establish
      motor neuron identity while antagonizing V2 and V3 interneuron differentiation.
    molecular_function:
      id: GO:0000981
      label: DNA-binding transcription factor activity, RNA polymerase II-specific
    directly_involved_in:
      - id: GO:0021522
        label: spinal cord motor neuron differentiation
      - id: GO:0045944
        label: positive regulation of transcription by RNA polymerase II
    locations:
      - id: GO:0005634
        label: nucleus
    anatomical_locations:
      - id: UBERON:0002240
        label: spinal cord
      - id: UBERON:0002028
        label: hindbrain

  - description: &gt;-
      OLIG2 binds E-box DNA sequences (CANNTG) through its bHLH domain, providing
      sequence-specific DNA recognition that underlies its transcriptional regulatory
      function in neural cell fate determination.
    molecular_function:
      id: GO:0070888
      label: E-box binding
    directly_involved_in:
      - id: GO:0006355
        label: regulation of DNA-templated transcription
    locations:
      - id: GO:0005634
        label: nucleus
      - id: GO:0000785
        label: chromatin

  - description: &gt;-
      OLIG2 forms homo- and heterodimers through its bHLH domain, which is essential
      for DNA binding and transcriptional activity. Phosphorylation at Serine 147
      regulates dimerization preference: phosphorylated OLIG2 forms homodimers that
      function as transcriptional repressors and promote motor neuron fate, while
      dephosphorylated OLIG2 forms heterodimers with NGN2 and E47, sequestering NGN2
      from pro-neural functions and promoting oligodendrocyte fate (PMID:21382552).
      OLIG2 also heterodimerizes with NKX2-2 and ZNF488 to regulate distinct aspects
      of neural development.
    molecular_function:
      id: GO:0046983
      label: protein dimerization activity
    directly_involved_in:
      - id: GO:0006355
        label: regulation of DNA-templated transcription
    locations:
      - id: GO:0005634
        label: nucleus

  - description: &gt;-
      OLIG2 functions as a chromatin pre-patterning factor that recruits the SWI/SNF
      chromatin remodeler BRG1/SMARCA4 to oligodendrocyte-specific enhancers before
      differentiation begins. Approximately 71% of BRG1 binding regions contain E-box
      motifs recognized by OLIG2. This OLIG2-BRG1 axis is required for initiating
      oligodendrocyte lineage progression. OLIG2 also recruits SETDB1 for H3K9me3
      repressive modification on genes like Sox11 that must be silenced during
      oligodendrocyte maturation.
    molecular_function:
      id: GO:0000981
      label: DNA-binding transcription factor activity, RNA polymerase II-specific
    directly_involved_in:
      - id: GO:0048709
        label: oligodendrocyte differentiation
      - id: GO:0006338
        label: chromatin remodeling
    locations:
      - id: GO:0000785
        label: chromatin
      - id: GO:0005634
        label: nucleus
    supported_by:
      - reference_id: file:human/OLIG2/OLIG2-deep-research-cyberian.md
        supporting_text: &#34;OLIG2 functions as a &#39;pre-patterning factor&#39; that directs BRG1 to oligodendrocyte-specific enhancers before differentiation begins&#34;
      - reference_id: file:human/OLIG2/OLIG2-deep-research-cyberian.md
        supporting_text: &#34;OLIG2 recruits the histone methyltransferase SETDB1 for H3K9me3 modification. This repressive epigenetic mechanism targets genes like Sox11&#34;

proposed_new_terms: []

suggested_questions:
  - question: What are the specific gene targets of OLIG2 in oligodendrocyte vs motor neuron specification programs?
  - question: How does OLIG2 switch from promoting motor neuron to oligodendrocyte fate at different developmental stages?
  - question: What is the role of OLIG2 phosphorylation and other post-translational modifications in regulating its activity?

suggested_experiments:
  - description: &gt;-
      ChIP-seq in neural progenitor cells to identify direct OLIG2 target genes
      and binding motifs in a mammalian cellular context.
    hypothesis: OLIG2 binds E-box sequences in promoters of oligodendrocyte and motor neuron specification genes
    experiment_type: ChIP-seq
  - description: &gt;-
      Time-course RNA-seq of OLIG2 knockout vs wild-type neural progenitors to
      identify genes regulated during motor neuron and oligodendrocyte differentiation.
    hypothesis: OLIG2 activates motor neuron and oligodendrocyte specification genes while repressing alternative neural fates
    experiment_type: RNA-seq
  - description: &gt;-
      Mass spectrometry-based identification of OLIG2 interaction partners in
      neural progenitor cells to characterize cell type-specific complexes.
    hypothesis: OLIG2 forms distinct transcriptional complexes during motor neuron vs oligodendrocyte specification
    experiment_type: IP-MS
</code></pre>
            </div>
        </details>
    </div>

    <!-- Pathway Visualization Link -->
    

    <style>
        /* Markdown Section Styles */
        .markdown-section {
            margin-bottom: 1rem;
            border: 1px solid #e0e0e0;
            border-radius: 8px;
            padding: 1rem;
            background-color: #f8f9fa;
        }

        .markdown-section summary {
            cursor: pointer;
            user-select: none;
        }

        .markdown-section summary h3 {
            margin: 0;
            color: #495057;
            font-size: 1.1rem;
        }

        .markdown-section summary:hover h3 {
            color: #007bff;
        }

        .markdown-section[open] {
            background-color: #fff;
        }

        .markdown-content {
            margin-top: 1rem;
            padding: 1rem;
            border-top: 1px solid #dee2e6;
        }

        /* Markdown content styling */
        .markdown-content h1 { font-size: 1.5rem; margin-top: 1.5rem; }
        .markdown-content h2 { font-size: 1.3rem; margin-top: 1.3rem; }
        .markdown-content h3 { font-size: 1.1rem; margin-top: 1.1rem; }
        .markdown-content h4 { font-size: 1rem; margin-top: 1rem; }

        .markdown-content pre {
            background-color: #f8f9fa;
            border: 1px solid #dee2e6;
            border-radius: 4px;
            padding: 1rem;
            overflow-x: auto;
        }

        .markdown-content code {
            background-color: #f8f9fa;
            padding: 0.2rem 0.4rem;
            border-radius: 3px;
            font-family: 'Courier New', Courier, monospace;
            font-size: 0.9rem;
        }

        .markdown-content pre code {
            background: none;
            padding: 0;
        }

        .markdown-content table {
            border-collapse: collapse;
            width: 100%;
            margin: 1rem 0;
        }

        .markdown-content table th,
        .markdown-content table td {
            border: 1px solid #dee2e6;
            padding: 0.5rem;
            text-align: left;
        }

        .markdown-content table th {
            background-color: #f8f9fa;
            font-weight: bold;
        }

        .markdown-content blockquote {
            border-left: 4px solid #007bff;
            padding-left: 1rem;
            margin-left: 0;
            color: #666;
        }

        /* YAML Preview Styles */
        .yaml-preview {
            margin-top: 2rem;
            border: 1px solid #e0e0e0;
            border-radius: 8px;
            padding: 1rem;
            background-color: #f8f9fa;
        }

        .yaml-preview summary {
            cursor: pointer;
            user-select: none;
        }

        .yaml-preview summary h2 {
            margin: 0;
            color: #495057;
            font-size: 1.3rem;
        }

        .yaml-preview summary:hover h2 {
            color: #007bff;
        }

        .yaml-preview[open] {
            background-color: #fff;
        }

        .yaml-content {
            margin-top: 1rem;
            background-color: #f8f9fa;
            border: 1px solid #dee2e6;
            border-radius: 4px;
            padding: 1rem;
            overflow-x: auto;
        }

        .yaml-content pre {
            margin: 0;
            font-family: 'Courier New', Courier, monospace;
            font-size: 0.9rem;
            line-height: 1.4;
        }

        .yaml-content code {
            color: #333;
            background: none;
            padding: 0;
        }

        /* Pathway Link Styles */
        .pathway-link {
            margin: 1rem 0;
        }

        .btn-link {
            display: inline-block;
            padding: 0.5rem 1rem;
            background-color: #007bff;
            color: white !important;
            text-decoration: none;
            border-radius: 4px;
            font-weight: 500;
            transition: background-color 0.2s;
        }

        .btn-link:hover {
            background-color: #0056b3;
            text-decoration: none;
        }

        /* Voting buttons */
        .vote-buttons {
            display: inline-block;
            margin-left: 0.5rem;
        }

        .vote-btn {
            background: none;
            border: 1px solid #dee2e6;
            border-radius: 4px;
            padding: 2px 6px;
            margin: 0 2px;
            cursor: pointer;
            font-size: 0.9rem;
            transition: all 0.2s;
            opacity: 0.6;
        }

        .vote-btn:hover {
            opacity: 1;
            transform: scale(1.1);
        }

        .vote-btn.voted {
            opacity: 1;
            border-color: #28a745;
            background-color: #d4edda;
        }

        .vote-btn.voted-down {
            border-color: #dc3545;
            background-color: #f8d7da;
        }

        .vote-btn-small {
            font-size: 0.7rem;
            padding: 1px 4px;
            margin: 0 1px;
        }
    </style>

    <script>
        // Add collapsible functionality
        document.querySelectorAll('.collapsible').forEach(element => {
            element.addEventListener('click', function() {
                this.classList.toggle('collapsed');
            });
        });

        // Voting functionality
        const VOTE_URL = 'https://script.google.com/macros/s/AKfycbwPKH7d3seuPNBtB0ugVjqGeTiByyOGD5vkqB_Ck6K8eOcPQYbJqBOuz6GFgXHKBNWK/exec';

        // Get or create session ID
        let sessionId = localStorage.getItem('review_session_id');
        if (!sessionId) {
            sessionId = 's' + Date.now() + '_' + Math.random().toString(36).substr(2, 9);
            localStorage.setItem('review_session_id', sessionId);
        }

        // Show previous votes on page load
        document.addEventListener('DOMContentLoaded', function() {
            document.querySelectorAll('.vote-buttons').forEach(container => {
                const key = `vote_${container.dataset.g}_${container.dataset.a}_${container.dataset.act}`;
                const previousVote = localStorage.getItem(key);
                if (previousVote) {
                    const btn = container.querySelector(`[data-v="${previousVote}"]`);
                    if (btn) btn.classList.add(previousVote === 'up' ? 'voted' : 'voted-down');
                }
            });
        });

        // Handle vote clicks - Simple image beacon approach
        document.addEventListener('click', function(e) {
            if (!e.target.classList.contains('vote-btn')) return;

            // Prevent the click from bubbling to parent elements (like summary)
            e.preventDefault();
            e.stopPropagation();

            const btn = e.target;
            const container = btn.closest('.vote-buttons');
            if (!container) return;

            const voteType = btn.dataset.v;

            // Check if already voted (locally)
            const key = `vote_${container.dataset.g}_${container.dataset.a}_${container.dataset.act}`;
            const previousVote = localStorage.getItem(key);

            if (previousVote === voteType) {
                // Same vote - do nothing
                btn.style.animation = 'shake 0.5s';
                setTimeout(() => btn.style.animation = '', 500);
                return;
            }

            // Build URL
            const params = new URLSearchParams({
                gene_id: container.dataset.g,
                annotation_id: container.dataset.a,
                ref_id: container.dataset.r || '',
                action: container.dataset.act,
                vote: voteType,
                session_id: sessionId,
                ua: navigator.userAgent.substring(0, 100)
            });

            // Clear previous vote styling
            container.querySelectorAll('.vote-btn').forEach(b => {
                b.classList.remove('voted', 'voted-down');
            });

            // Apply new vote styling immediately (optimistic UI)
            btn.classList.add(voteType === 'up' ? 'voted' : 'voted-down');

            // Store locally
            localStorage.setItem(key, voteType);

            // Send vote using fetch with no-cors mode (fire and forget)
            const fullUrl = VOTE_URL + '?' + params;
            console.log('Sending vote to:', fullUrl);

            // Use fetch in no-cors mode - we won't get a response but the request will be sent
            fetch(fullUrl, {
                mode: 'no-cors',
                method: 'GET'
            }).then(() => {
                console.log('Vote request sent (no response due to no-cors mode)');
            }).catch(err => {
                console.warn('Vote may not have been recorded, but saved locally:', err);

                // Fallback: try image beacon as well
                const img = new Image();
                img.src = fullUrl;
            });
        });

        // Optional: Add shake animation for feedback
        const style = document.createElement('style');
        style.textContent = `
            @keyframes shake {
                0%, 100% { transform: translateX(0); }
                25% { transform: translateX(-5px); }
                75% { transform: translateX(5px); }
            }
        `;
        document.head.appendChild(style);
    </script>
</body>
</html>